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A B S T R A C T
Background
Governments use different approaches to ensure that private for-profit healthcare services meet certain quality standards. Such gov-
ernment guidance, referred to as public stewardship, encompasses government policies, regulatory mechanisms, and implementation
strategies for ensuring accountability in the delivery of services. However, the effectiveness of these strategies in low- and middle-income
countries (LMICs) have not been the subject of a systematic review.
Objectives
To assess the effects of public sector regulation, training, or co-ordination of the private for-profit health sector in low- and middle-
income countries.
Search methods
For related systematic reviews, we searched the Cochrane Database of Systematic Reviews (CDSR) 2015, Issue 4; Database of Abstracts
of Reviews of Effectiveness (DARE) 2015, Issue 1; Health Technology Assessment Database (HTA) 2015, Issue 1; all part of The
Cochrane Library, and searched 28 April 2015. For primary studies, we searched MEDLINE, Epub Ahead of Print, In-Process &
Other Non-Indexed Citations, MEDLINE Daily and MEDLINE 1946 to Present, OvidSP (searched 16 June 2016); Science Citation
Index and Social Sciences Citation Index 1987 to present, and Emerging Sources Citation Index 2015 to present, ISI Web of Science
(searched 3 May 2016 for papers citing included studies); Cochrane Central Register of Controlled Trials (CENTRAL), 2015, Issue 3,
part of The Cochrane Library (including the Cochrane Effective Practice and Organisation of Care (EPOC) Group Specialised Register)
(searched 28 April 2015); Embase 1980 to 2015 Week 17, OvidSP (searched 28 April 2015); Global Health 1973 to 2015 Week 16,
OvidSP (searched 30 April 2015); WHOLIS, WHO (searched 30 April 2015); Science Citation Index and Social Sciences Citation
Index 1975 to present, ISI Web of Science (searched 30 April 2015); Health Management, ProQuest (searched 22 November 2013).
In addition, in April 2016, we searched the reference lists of relevant articles, WHO International Clinical Trials Registry Platform,
Clinicaltrials.gov, and various electronic databases of grey literature.
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Selection criteria
Randomised trials, non-randomised trials, interrupted time series studies, or controlled before-after studies.
Data collection and analysis
Two authors independently assessed study eligibility and extracted data, comparing their results and resolving discrepancies by consensus.
We expressed study results as risk ratios (RR) or mean differences (MD) with 95% confidence intervals (CI), where appropriate, and
assessed the certainty of the evidence using Grades of Recommendation, Assessment, Development and Evaluation (GRADE). We did
not conduct meta-analysis because of heterogeneity of interventions and study designs.
Main results
We identified 20,177 records, 50 of them potentially eligible. We excluded 39 potentially eligible studies because they did not involve a
rigorous evaluation of training, regulation, or co-ordination of private for-profit healthcare providers in LMICs; five studies identified
after the review was submitted are awaiting assessment; and six studies met our inclusion criteria. Two included studies assessed training
alone; one assessed regulation alone; three assessed a multifaceted intervention involving training and regulation; and none assessed co-
ordination. All six included studies targeted private for-profit pharmacy workers in Africa and Asia.
Three studies found that training probably increases sale of oral rehydration solution (one trial in Kenya, 106 pharmacies: RR 3.04,
95% CI 1.37 to 6.75; and one trial in Indonesia, 87 pharmacies: RR 1.41, 95% CI 1.03 to 1.93) and dispensing of anti-malarial drugs
(one trial in Kenya, 293 pharmacies: RR 8.76, 95% CI 0.94 to 81.81); moderate-certainty evidence.
One study conducted in the Lao People’s Democratic Republic shows that regulation of the distribution and sale of registered phar-
maceutical products may improve composite pharmacy indicators (one trial, 115 pharmacies: improvements in four of six pharmacy
indicators; low-certainty evidence).
The outcome in three multifaceted intervention studies was the quality of pharmacy practice; including the ability to ask questions,
give advice, and provide appropriate treatment. The trials applied regulation, training, and peer influence in sequence; and the study
design does not permit separation of the effects of the different interventions. Two trials conducted among 136 pharmacies in Vietnam
found that the multifaceted intervention may improve the quality of pharmacy practice; but the third study, involving 146 pharmacies
in Vietnam and Thailand, found that the intervention may have little or no effects on the quality of pharmacy practice (low-certainty
evidence).
Only two studies (both conducted in Vietnam) reported cost data, with no rigorous assessment of the economic implications of
implementing the interventions in resource-constrained settings. No study reported data on equity, mortality, morbidity, adverse effects,
satisfaction, or attitudes.
Authors’ conclusions
Training probably improves quality of care (i.e. adherence to recommended practice), regulation may improve quality of care, and
we are uncertain about the effects of co-ordination on quality of private for-profit healthcare services in LMICs. The likelihood that
further research will find the effect of training to be substantially different from the results of this review is moderate; implying that
monitoring of the impact is likely to be needed if training is implemented. The low certainty of the evidence for regulation implies
that the likelihood of further research finding the effect of regulation to be substantially different from the results of this review is
high. Therefore, an impact evaluation is warranted if government regulation of private for-profit providers is implemented in LMICs.
Rigorous evaluations of these interventions should also assess other outcomes such as impacts on equity, cost implications, mortality,
morbidity, and adverse effects.
P L A I N L A N G U A G E S U M M A R Y
Government regulation, training, or co-ordination of private for-profit health care in low- and middle-income countries
What is the aim of this review?
The aim of this Cochrane review was to evaluate the effect of government regulation, training, or co-ordination of private for-profit
health care in low- and middle-income countries.
We collected and analysed all relevant studies to answer this question and included six studies in the review.
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Why do governments regulate, train or co-ordinate private healthcare providers?
In many low- and middle-income countries, the public sector is not able to provide high quality healthcare services to all citizens, and
private healthcare providers therefore play a major role. However, there is concern that health care provided by the private sector is not
always of high quality and that recommended practices and guidelines are not always followed. Governments therefore use different
approaches to ensure that private for-profit healthcare services meet certain quality standards. This type of government guidance
is referred to as ’public stewardship’ and can for instance involve training and education for private for-profit healthcare providers;
introduction of regulations where quality standards are set and enforced; and co-ordination between private for-profit and public sector
healthcare providers, for instance, creating referral systems between the private for-profit and public sectors.
What happens when governments regulate, train or co-ordinate private, for-profit health care providers?
Training
In two studies in Kenya and Indonesia, the Ministry of Health offered private drug sellers short training sessions on prescribing and
dispensing drugs. These sellers were compared to drug sellers whowere not offered training. The studies suggested that training probably
improves the quality of healthcare services.
Regulation
In one study in the Lao People’s Democratic Republic, the Ministry of Health supervised private pharmacy services in certain districts
over a three-month period, applied sanctions when rules were broken, and offered information about areas needing improvement.
These districts were compared to districts without this enhanced supervision. The study suggested that this enhanced regulation may
make little or no difference to quality of care.
Training and regulation
In three studies in Vietnam and Thailand, private pharmacies in some districts received educational visits as well as visits from pharmacy
inspectors to enforce regulations. These districts were compared to districts that did not receive any visits. The studies suggested that
these types of visits may improve quality of care.
Co-ordination
The review did not find any eligible study that assessed the effects of co-ordination on quality of care.
How up-to-date is this review?
The review authors searched for studies that had been published up to June 2016.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Training compared to no training for improving quality of care
Population: Private for-prof it providers of healthcare services
Settings: Kenya and Indonesia (1 study) and Kenya (1 study)
Intervention: Training
Comparison: No training
Outcomes Impacts No of Participants
(studies)
Certainty of the evidence
(GRADE)
Quality of care Both studies show that train-
ing probably improves the
quality of healthcare services
486 pharmacies
(2 studies)
⊕⊕⊕©
Moderate*
* We downgraded the certainty of evidence by 1 point, because of a moderate risk of select ion bias in included studies
GRADE Working Group grades of evidence
High certainty: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate certainty: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and
may change the est imate.
Low certainty: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is
likely to change the est imate.
Very low certainty: We are very uncertain about the est imate.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
B A C K G R O U N D
The public health sector in low- and middle-income countries is
not always sufficiently well-equipped and financed to provide high
quality health care that is accessible to all citizens (Basu 2012;
Lagomarsino 2009). The consequence of this public sector fail-
ure has been a proliferation in private providers of healthcare ser-
vices in most of the countries (Forsberg 2011; Levin 2011; Scott
2011). Governments have a responsibility to ensure the quality
of healthcare services delivered by private providers, to expand
the coverage of existing private providers, and to rationalise this
coverage with that of public sector providers (Waters 2003). Such
government guidance is referred to as public stewardship. How-
ever, there is a paucity of high quality research evidence on the
effects of public stewardship on the quality and accessibility of
private for-profit health care in low- and middle-income countries
(Patouillard 2007; Waters 2003); thus the need for this review.
Description of the condition
The private health sector is not homogeneous, but consists of not-
for-profit and for-profit as well as formal and informal providers
of healthcare services (Basu 2012; Sulzbach 2011). Private not-
for-profit healthcare providers refer to healthcare organisations
that use any surplus revenues to achieve their goals, rather than
distributing them as dividends. On the other hand, the private
for-profit sector refers to the part of the economy that is run by
individuals and companies for profit and is not state-controlled.
The consequence of the expansion in the private health sector in
LMICs is that (poor) communities spend outsized amounts of
money for private healthcare services; at timeswhen cheaper public
sector alternatives are available (Forsberg 2011; Patouillard 2007).
However, the quality of the services provided by the private for-
profit healthcare sector in LMICs is increasingly being questioned
(Berendes 2011; Waters 2003).
Description of the intervention
The growing concern regarding the technical failures of health
care provided by the private for-profit sector has led to the de-
velopment of interventions aimed at addressing these limitations,
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which simultaneously take advantage of the potential for involving
the private for-profit sector to achieve public health goals. This
review assessed the public stewardship of private for-profit health-
care providers in LMICs. Stewardship can be defined as a function
of governments responsible for the welfare of their populations
(Veillard 2011). It involves policy guidance to the whole health
system, co-ordination between actors and regulation of different
functions, levels and actors in the system, an optimal allocation
of resources and accountability towards all stakeholders. Although
many actors have an influence on stewardship, there is a central
role for the government in ensuring equity, efficiency and sustain-
ability of the health system (Van Olmen 2010). Therefore, stew-
ardship entails oversight and guidance of the whole system; en-
suring strategic policy frameworks exist and are combined with
effective oversight, coalition-building, regulation, attention to sys-
tem-design and accountability. The stewardship function involves
the role of the government in health and its relation to other ac-
tors whose activities impact on health. Public stewardship encom-
passes government policies, regulatory mechanisms, and imple-
mentation strategies for ensuring guidance and accountability in
which healthcare services are delivered; in order to protect the pub-
lic interest (WHO 2007). While ultimately it is the responsibility
of government, this does not mean all stewardship functions have
to be carried out by central ministries of health (WHO 2009).
Various strategies have been proposed for improving the function-
ing of the private for-profit health sector in order to increase the
quality, availability, and affordability of health care for poor peo-
ple in LMICs (Lagomarsino 2009; Levin 2011; Patouillard 2007;
Waters 2003). These strategies include regulation, contracting-
out, social marketing, franchising, use of vouchers, training, pay
for performance, accreditation, and co-ordination. The strategies
use various markers of success which are analysed by their asso-
ciation with differences in performance of intermediate goals or
outcomes (Travis 2002). We focused on three types of strategic
interventions, namely, regulation, training, and co-ordination of
private for-profit providers. In the context of this review, regula-
tion refers to the setting and enforcing of standards for the private
for-profit sector; training involves educating and supporting pri-
vate for-profit service providers; and co-ordination entails organ-
ising and creating alliances between private for-profit and public
sector healthcare providers. We excluded public stewardship inter-
ventions which are already covered by other Cochrane reviews; in-
cluding social marketing and franchising (Koehlmoos 2009), con-
tracting (Lagarde 2009), and pay for performance (Witter 2012).
How the intervention might work
Regulatory interventions take the form of rules, enforcement sys-
tems and sanction mechanisms, and can be applied at the levels of
the healthcare provider, organisation, or facility. At the provider
level, regulationmay include requirements for pre-service training,
continuing education, licensing, and certification. At the organi-
sational or facility level, regulation may aim to control the location
of facilities, their registration, prices, and minimum complement
of staff or facilities. For example, pharmaceutical market regula-
tion aims to limit the availability of harmful drugs and unregis-
tered products, minimise drug misuse, control the sale of specific
drugs through prescriptions, and control drug manufacture and
importation. Training interventions may involve formal educa-
tional sessions (educational meetings and workshops), vendor-to-
vendor education, distribution of guidelines, printed educational
materials, educational outreach i.e. a personal visit by a trained
government official to private for-profit healthcare providers in
their own settings, or audit and feedback i.e. a summary of the
performance of private for-profit providers over a specified period
of time given in a verbal or written format; alone or in combina-
tion (Forsetlund 2009; Jamtvedt 2006; O’Brien 2007; Patouillard
2007). A wide variety of private for-profit healthcare sector com-
ponents could be targeted for training, including physicians, phar-
macists, midwives, nurses, and traditional healers. Finally, govern-
ment co-ordination of private for-profit health care ensures har-
monised minimum standards for health service delivery across ge-
ographic areas and social groups (Waters 2003). For instance, the
creation of referral systems between the private for-profit and pub-
lic sector and ensuring that health professionals in different health
sectors understand their roles in disease management. The ulti-
mate aim of government regulation, training, and co-ordination
of the private for-profit health sector is to promote equity, better
health outcomes, and financial protection (Lagomarsino 2009).
Why it is important to do this review
A systematic review published in 2007 found “evidence that effec-
tive public-private partnerships can increase access, improve eq-
uity, and raise quality of health services“ (Patouillard 2007). How-
ever, using the GRADE approach (Balshem 2011; Guyatt 2008),
this evidence on the effectiveness of interventions for working
with the private for-profit sector to improve the utilisation and
quality of health services for the poor in low- and middle-income
countries was found to be of low certainty (Wiysonge 2008). The
implication of the low certainty of the evidence is that further
research on this topic is very likely to have an important impact
on our confidence in the estimate of effect and is likely to change
the estimate. It is possible that additional primary studies may
have been conducted on this topic. Therefore, we reviewed the
currently available evidence on public sector efforts to work with
private for-profit health service providers to improve the quality of
existing healthcare services as well as expand and rationalise their
coverage (Waters 2003).
O B J E C T I V E S
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To assess the effects of public sector regulation, training, or co-or-
dination of the private for-profit health sector in low- and middle-
income countries.
M E T H O D S
Criteria for considering studies for this review
Types of studies
The studies eligible for inclusion in the review were:
• randomised trials, including individually-randomised and
cluster-randomised trials;
• non-randomised controlled trials i.e. experimental studies
in which people are allocated to different interventions using
methods that are not random;
• interrupted time series studies with at least three
measurements before and after introducing the intervention; and
• controlled before-after studies with at least two intervention
groups and at least two comparable control groups, with
simultaneous data collection (EPOC 2013).
Types of participants
Studies taking place in low- and middle-income countries as de-
fined by the World Bank. All types of health services provided by
for-profit providers were eligible for inclusion in this review.
Types of interventions
Regulation, training, and co-ordination of any intensity or du-
ration, implemented by the public sector. The control group re-
ceived no intervention or an alternative intervention.
Types of outcome measures
The outcomes of interest were as follows.
Primary outcomes
• Quality of care (defined as adherence to recommended
practice or guidelines).
Secondary outcomes
• Equity
• Mortality or morbidity
• Adverse effects (e.g. undesirable impacts on existing public
or private services, inappropriate use of services, and distortion
in the provision of services)
• Satisfaction
• Attitudes
• Costs of implementing the interventions
Search methods for identification of studies
We developed a sensitive and previously validated search strategy
for randomised trials, non-randomised trials, controlled before-
after studies, and interrupted time series studies combined with
relevant medical subject headings (MeSH) and free-text terms re-
lating to health regulation, training and co-ordination literature
for low- and middle-income countries. We placed no language or
date restrictions on the search strategy. We translated the MED-
LINE (Ovid) search strategy into the other databases using the
appropriate controlled vocabulary.
Electronic searches
We searched the following databases for systematic reviews:
• Cochrane Database of Systematic Reviews (CDSR) 2015,
Issue 4, part of The Cochrane Library. www.cochranelibrary.com
(searched 28 April 2015)
• Database of Abstracts of Reviews of Effectiveness (DARE)
2015, Issue 1, part of The Cochrane Library.
www.cochranelibrary.com (searched 28 April 2015)
• Health Technology Assessment Database (HTA) 2015,
Issue 1, part of The Cochrane Library.www.cochranelibrary.com
(searched 28 April 2015).
We searched the following databases, with no language or date
restrictions, for primary studies:
• MEDLINE, Epub Ahead of Print, In-Process & Other
Non-Indexed Citations, MEDLINE Daily and MEDLINE 1946
to Present, OvidSP (searched 16 June 2016)
• Science Citation Index and Social Sciences Citation Index
1987 to present, and Emerging Sources Citation Index 2015 to
present, ISI Web of Science (searched 3 May 2016 for papers
citing included studies)
• Cochrane Central Register of Controlled Trials
(CENTRAL), 2015, Issue 3, part of the Cochrane Library.
www.cochranelibrary.com (including the Cochrane Effective
Practice and Organisation of Care (EPOC) Group Specialised
Register) (searched 28 April 2015)
• Embase 1980 to 2015 Week 17, OvidSP (searched 28 April
2015)
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• Global Health 1973 to 2015 Week 16, OvidSP (searched
30 April 2015)
• WHOLIS, WHO (searched 30 April 2015)
• Science Citation Index and Social Sciences Citation Index
1975 to present, ISI Web of Science (searched 30 April 2015)
• Health Management, ProQuest (searched 22 November
2013).
Searching other resources
In April 2016 we searched the following databases and websites
for eligible studies:
• OpenGrey (opengrey.eu)
• Grey Literature Report (greylit.org)
• World Bank e-Library (elibrary.worldbank.org)
• US National Institutes of Health (NIH) (nih.gov)
• United Nations Children’s Fund (UNICEF) (unicef.org)
• Alliance for Health Policy and Systems Research (who.int/
alliance-hpsr/en)
• United States Agency for International Development
(USAID) (usaid.gov)
• Gavi, The Vaccine Alliance (gavi.org)
• Private Healthcare in Developing Countries (ps4h.org)
• Population Services International (PSI) (psi.org)
• Shops (shopsproject.org)
• United Kingdom Department for International
Development (gov.uk/government/organisations/department-
for-international-development)
• Center For Health Market Innovations (
healthmarketinnovations.org
• World Bank (worldbank.org)
Trial Registries
• International Clinical Trials Registry Platform (ICTRP),
Word Health Organization (WHO) (who.int/ictrp/en) (searched
April 2016)
• ClinicalTrials.gov (clinicaltrials.gov) (searched April 2016)
We checked the reference lists of identified reviews (Basu 2012;
Berendes 2011; Forsberg 2011; Forsetlund 2009; Levin 2011;
Patouillard 2007; Sulzbach 2011;Waters 2003) as well as reference
lists of full-text articles reviewed for inclusion in this review.
Data collection and analysis
Selection of studies
Two authors (Leila Abdullahi and Valantine Ndze, Leila Abdullahi
and CharlesWiysonge, or Valantine Ndze and CharlesWiysonge)
screened the titles and abstracts of outputs from the searches using
a pre-designed screening guide to identify potentially eligible stud-
ies. We retrieved the full text of all publications deemed poten-
tially eligible by at least one of the two authors. The two authors
then independently examined each of these for eligibility. Each
author compiled a list of studies which he or she believed met the
inclusion criteria. Both authors compared the lists and resolved
discrepancies by discussion and consensus.
Data extraction and management
The two authors independently extracted descriptive and outcome
data from each included study using a pre-designed data collec-
tion form. Both authors compared extracted data, resolving any
discrepancies by discussion and consensus, failing which a third
author would have arbitrated. One of two authors (Leila Abdul-
lahi and CharlesWiysonge) entered the data into ReviewManager
(RevMan) 5.3 (RevMan 2014) and the other author performed
double checks to ensure that there were no errors in the data en-
tered.
Assessment of risk of bias in included studies
We assessed the risk of bias based on six standard domains:
• Sequence generation
• Concealment of allocation
• Blinded or objective assessment of primary outcome(s)
• Incomplete outcome data
• Selective outcome reporting; and
• Other sources of bias (Higgins 2011a).
We also used three additional criteria specified by theCochrane Ef-
fective Practice and Organisation of Care Group (EPOC) (EPOC
2015):
• Similar baseline characteristics
• Similar baseline outcome measures
• Reliable primary outcome measures; and
• Adequate protection against contamination.
For each included study, two authors independently reported their
assessment of the risk of bias for each domain (i.e. low, high, or
unclear) together with a descriptive summary of the information
that influenced their judgment. The two authors compared the
results of their independent assessments of the risk of bias and
resolved any discrepancies by discussion and consensus. Had the
two authors failed to reach an agreement, a third author would
have arbitrated.
Measures of treatment effect
We grouped measures of treatment effect based on outcome vari-
ables and study designs. We recorded and used estimates of effect
from the primary analysis reported by the investigators.
We anticipated that there would be important baseline differences
between intervention and control groups and planned to base our
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primary analyses for trials and controlled before-after studies on
estimates of effect that were adjusted for baseline differences. For
dichotomous outcomes we planned to calculate the adjusted risk
difference as the difference in adherence after the intervention mi-
nus the difference before the intervention. A positive risk differ-
ence would indicate that compliance with the recommended prac-
tice improved more in the intervention group than in the control
group (e.g. an adjusted risk difference of 0.11 would indicate an
absolute improvement in compliance with targeted behaviours of
11%). For continuous outcomes we planned to calculate the ad-
justed change relative to the control group as the post-intervention
difference in means minus the baseline difference in means di-
vided by the baseline control groupmean. Aswith the adjusted risk
difference, a positive change would indicate that compliance im-
proved more in the intervention group than in the control group.
This is a relative effect rather than an absolute effect; the effect
size reflects the baseline performance as well as the change in per-
formance and it is not bound between -100% and +100%.
We planned to analyse interrupted time series studies using ei-
ther a regression analysis with time trends before and after the
intervention, which adjusts for auto-correlation and any periodic
changes; or any other technique that adjusts for auto-correlation
and periodic changes. We would present results for the outcomes
as changes along two dimensions: change in level and change in
slope. Change in level is the immediate effect of the policy and
change in slope is the change in the trend from pre- to post-inter-
vention. It reflects the long-term effect of the intervention.
For all measures we planned to calculate 95% confidence intervals
(CI).
Unit of analysis issues
We planned that if investigators reported cluster-randomised trial
data as if the randomisation was performed on the individuals
rather than the clusters, we would request the intra-cluster corre-
lation coefficient from the study authors; failing which we would
obtain external estimates of the intra-cluster correlation coefficient
from similar studies or available resources. Once established, we
would use the intra-cluster correlation coefficient to re-analyse the
trial data to obtain approximate correct analyses; as described in
the Cochrane Handbook for Systematic Reviews of Interventions
(Deeks 2011). We planned to combine the effect estimates and
their corrected standard errors from cluster-randomised trials with
those from parallel group designs using the generic inverse vari-
ance method (Deeks 2011). If insufficient information was avail-
able to control for clustering in this way, we would enter data into
RevMan using individuals as the unit of analysis. We would then
perform sensitivity analyses to assess the potential bias that may
have occurred as a result of the inadequately controlled cluster-
randomised trials. We planned that we would also perform sensi-
tivity analyses if the intra-cluster correlation coefficients were ob-
tained from external sources to assess the potential biasing effects
of inadequately controlled cluster-randomised trials.
Three included studies were cluster-randomised trials based on
matched pairs of clusters (Chalker 2002; Chuc 2002; Stenson
2001). We did not re-analyse these data as matching cannot be
taken into account in re-analyses in such studies unless the raw
data are available. The studies, however, conducted appropriate
analyses of the data, and we have provided the results as reported
in the studies. We have re-analysed the data for the fourth cluster-
randomised trial (Abuya 2009). We did not conduct a meta-anal-
ysis.
Dealing with missing data
We planned that where necessary, we would contact the corre-
sponding authors of included studies to supply any unreported
data. If the corresponding author did not respond within one
week of our request, we planned to contact other authors (copy-
ing the corresponding author). If a study reported outcomes only
for participants completing the trial or only for participants who
followed the protocol, we planned to contact the authors and ask
them to provide additional information to permit us to conduct
meta-analyses by intention-to-treat. We would describe missing
data and dropouts for each included study in the risk of bias table,
and discuss the extent to which the missing data could alter our
results. We planned to conduct sensitivity analyses to assess the
effect of missing data on our primary meta-analyses. If we had at
least 10 studies in a meta-analysis, we would have explored the
impact of including trials with high levels of missing data in the
overall assessment of intervention effects by using sensitivity anal-
yses.
For the current version of the review, we did not contact the pri-
mary study authors for missing data. We identified levels of attri-
tion for included trials and performed analyses for reported out-
comes. All participants were analysed in the group to which they
were allocated, regardless of whether or not they received the allo-
cated intervention. We assumed thatmissing participants did have
the outcome of interest, and did not conduct sensitivity analyses
imputing values for the outcome status of missing participants.
Assessment of heterogeneity
Given the variation found across studies in relation to the inter-
ventions, study design and outcome measures, we have not con-
ducted a meta-analysis of study results. A statistical assessment of
heterogeneity of results was therefore not done.
If we found homogeneous studies of similar interventions that re-
ported similar outcomes, we would have conducted a meta-anal-
ysis, examined statistical heterogeneity between study results us-
ing the Chi2 test of homogeneity (with significance defined at the
alpha-level of 10%) (Deeks 2011), and quantified any statistical
heterogeneity between study results using the I2 statistic (Higgins
2003).
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Assessment of reporting biases
We employed strategies to search for and include relevant unpub-
lished studies in order to reduce possible publication bias. These
strategies included searching the grey literature and prospective
trial registration databases to overcome time-lag bias.
Data synthesis
Due to important heterogeneity between studies, a pooled statis-
tical analysis of the results was not possible. Therefore we did a
qualitative analysis based on intervention and outcome measures.
If we had identified two or more clinically homogenous studies
with similar interventions and comparison groups that reported
similar outcome measures, we would have used meta-analysis to
estimate the overall effect across those studies. We would have
calculated all overall effects, if applicable, using inverse variance
methods.
We used the GRADE approach to summarise the certainty of the
evidence for each outcome (Guyatt 2008).The GRADE approach
results in an assessment of the certainty of a body of evidence as
high, moderate, low, or very low. High certainty evidence implies
that ”further research is very unlikely to change our confidence
in the estimate of effect“. Moderate certainty evidence means that
”further research is likely to have an important impact on our con-
fidence in the estimate of effect and may change the estimate“.
Evidence is considered of low certainty if ”further research is very
likely to have an important impact on our confidence in the esti-
mate of effect and is likely to change the estimate“, and very low
quality if ”we have very little confidence in the effect estimate“
(Balshem 2011).
Subgroup analysis and investigation of heterogeneity
We stratified analysis by type of intervention. We did not find any
studies that were similar enough to combine in a meta-analysis
and, therefore, we did not conduct any subgroup analyses.
Sensitivity analysis
If we had found 10 or more studies that were similar enough that
it would be sensible to combine them in ameta-analysis, we would
have conducted sensitivity analyses to investigate the robustness of
the results to risk of bias (i.e. omitting any studies with high risk
of bias) and method of meta-analysis (i.e. random-effects versus
fixed-effect).
R E S U L T S
Description of studies
Results of the search
Our search yielded 20,177 titles and abstracts. After removing
1,419 duplicates , we screened 18,758 records; 18,708 of which
were not relevant.We reviewed the 50 potential eligible articles for
inclusion. Six of these studies met our inclusion criteria (Abuya
2009; Chalker 2002; Chalker 2005; Chuc 2002; Ross-Degnan
1996; Stenson 2001), and we excluded 39 for reasons given in
the Characteristics of excluded studies. Five studies were identified
after the review was submitted and are awaiting assessment (see
Characteristics of studies awaiting classification). We present the
search and selection of studies for this review in Figure 1.
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Figure 1. Study flow diagram
Included studies
We included six randomised trials on regulation and training of
private for-profit healthcare providers in low- and middle-income
countries (Abuya 2009; Chalker 2002; Chalker 2005; Chuc 2002;
Ross-Degnan 1996; Stenson 2001). One study (Ross-Degnan
1996) had two components; one being a randomised trial, and
the other a non-randomised trial. Five studies assessed training
(Abuya 2009; Chalker 2002; Chalker 2005; Chuc 2002; Ross-
Degnan 1996), four studies assessed regulation (Chalker 2002;
Chalker 2005; Chuc 2002; Stenson 2001), and no study assessed
co-ordination.
Description of interventions
Two studies (Abuya 2009; Ross-Degnan 1996) assessed only train-
ing interventions (N=486pharmacies), one study (Stenson 2001)
assessed regulation only (N = 115 pharmacies), and three studies
(Chalker 2002; Chalker 2005; Chuc 2002) had a multifaceted
intervention which combined training, regulation, and peer influ-
ence (N = 379 pharmacies). All six studies targeted private phar-
macy workers or drug retailers.
Training
The intervention in the two ’training-only’ studies consisted of
short-duration training sessions of one or two days in Kenya (
Abuya 2009; Ross-Degnan 1996) and Indonesia (Ross-Degnan
1996). In both studies drug sellers were trained on prescription
and dispensing of drugs, and surrogate patients (i.e. simulated
clients) were used to assess the effects of the intervention on the
quality of care provided by the trained retailers. The training was
provided by the Ministry of Health in each country.
Regulation
One study (Stenson 2001) assessed regulation only (N = 115
pharmacies). The regulatory intervention involved three-month
intensive supervision of pharmacy services in the Lao People’s
Democratic Republic, applying sanctionswhen rules were violated
and providing up-to-date regulatory documents and information
about particular areas needing improvements (Stenson 2001). The
study compared districts with active regulation to districts with
only ”regular supervision“. The ’regular supervision’ intervention
package was implemented in the way and speed that would have
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taken place in the absence of the study. The aim was to let the con-
trol districts follow their natural course. The intervention was pro-
vided by the Ministry of Health with assistance from the United
Nations Children’s Fund (Stenson 2001).
Multifaceted intervention
Three studies (Chalker 2002; Chalker 2005; Chuc 2002) had a
multifaceted intervention which combined training, regulation,
and peer influence (N = 379 pharmacies). Each intervention
lasted three months, with a gap of four months before the next
intervention. The quality of practice after the intervention was
assessed through simulated clients. Two studies (Chalker 2002;
Chuc 2002) were performed in Hanoi (Vietnam) with the in-
tervention delivered by the Hanoi Health Bureau and the Hanoi
Pharmacy Association. One study (Chalker 2005) was performed
in both Hanoi (Vietnam) and Bangkok (Thailand); with the in-
tervention delivered by the Hanoi Health Bureau and the Hanoi
Pharmacy Association in Vietnam and the Bangkok Health Sys-
temResearch Institute and theCommunity Pharmacy Association
in Thailand. The studies compared pharmacies with the multi-
faceted intervention to pharmacies without any intervention. All
pharmacists who received the multifaceted intervention received
all three interventions as a set. Enforcement regulation was per-
formed by pharmacy inspectors while the educational interven-
tion consisted of educational visits by senior researchers. Peer in-
fluence involved a number of group leaders and representatives
of the pharmacy associations, who attended seminars where the
research group informed them about the peer influence strategy
and reviewed management.
Co-ordination
We did not identify any study that assessed the effects of govern-
ment co-ordination of private for-profit healthcare providers, such
as the creation of referral systems between the private for-profit
and public sectors.
Description of outcomes
All six included studies reported on change in quality of care.
The latter was measured using different dimensions in the dif-
ferent studies. One study (Stenson 2001) that assessed only reg-
ulation measured quality of care through change in the quality
of private pharmacy practices (using ”pharmacy indicators“). The
two studies (Abuya 2009; Ross-Degnan 1996) that assessed only
training measured quality of care through correct management of
childhoodmalaria or diarrhoea respectively. The three studies with
multifaceted interventions (Chalker 2002; Chalker 2005; Chuc
2002)measured quality of care through change in the correctman-
agement of tracer conditions, antibiotic dispensing practices, and
correct symptomatic treatment of sexually transmitted infections
respectively. Two studies (Chuc 2002; Chalker 2002) reported the
cost of implementing the interventions.
No studies reported data on equity, mortality, morbidity, adverse
effects, satisfaction, or attitudes.
Excluded studies
We excluded 34 studies (Akoria 2008; Akol 2014; Ali 2011;
Ali 2012; Andrianasolo 2012; Bhat 1996; Bojalil 1999;
Chakraborty 2000; Contiades 2007; Dholakia 2013; Farsi 1999;
Fernandes 2009; Goodman 2007; Grundy 2010; Guiscafre 2001;
Harrison 2000; Hongoro 2000; Kangwana 2011; Khan 2006;
Kumaranayake 2000; Maiga 2010; Marsh 2004; Minh 2013;
Murugesan 2009; Nsimba 2007; Obua 2004; Okonofua 2003;
Osterholt 2009; Rutta 2011; Stenson 2001b; Syhakhang 2001;
Tavrow 2003; Tumwikirize 2004; Willey 2014) for reasons given
in the table of Characteristics of excluded studies. The most com-
mon reason for exclusion was an ineligible study design.
Risk of bias in included studies
Wehave summarised our judgements about the risk of bias in each
included study in Figure 2 and Figure 3.
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
The methods for generation of the randomisation sequence and
allocation concealment were unclear in all six studies (Abuya 2009;
Chalker 2002; Chalker 2005; Chuc 2002; Ross-Degnan 1996;
Stenson 2001).
Blinding
Outcome assessors were blinded in two studies (Abuya 2009; Ross-
Degnan 1996), but there was no description of blinding in the
rest (Chalker 2002; Chalker 2005; Chuc 2002; Stenson 2001).
Incomplete outcome data
Loss to follow up was moderate to high in the six studies.
Selective reporting
Selective reporting was categorised as unclear since we had no
access to the study protocols.
Other potential sources of bias
All studies reported similar baseline characteristics among the
intervention and control groups. Two studies (Chalker 2002;
Chalker 2005) reported small differences in the outcomemeasures
at baseline while no description was provided on baseline outcome
measures in the rest of the studies. In one cluster-randomised con-
trolled trial there was some degree of contamination in a cluster
that was meant to be a control cluster (Abuya 2009), but none of
the other studies reported contamination of control clusters with
the interventions assessed.We did not have any evidence that other
biases were introduced into the remaining studies, over and above
the ones reported above.
Effects of interventions
See: Summary of findings for the main comparison
Government training of private for-profit healthcare providers;
Summary of findings 2 Government regulation of private for-
profit healthcare providers; Summary of findings 3 Government
training and regulation of private for-profit healthcare providers
Primary outcome
All six included studies reported effects on quality of care; al-
though quality of care was measured using different indicators.
Three studies focused on improving treatment of childhood ill-
nesses such as acute respiratory infection, malaria, or diarrhoea
(Abuya 2009; Chalker 2002; Ross-Degnan 1996); one assessed
the quality of treatment of sexually transmitted infections (Chuc
2002); and two assessed antibiotic dispensing practices (Chalker
2005; Chuc 2002).
Training
Each of the two studies that assessed training alone (Abuya 2009;
Ross-Degnan 1996) observed improvements in quality of care.
The study conducted in Kenya and Indonesia (Ross-Degnan
1996) showed an overall improvement in the management of di-
arrhoea among counter attendants in the intervention pharmacies
compared to the controls. The sale of oral rehydration solution in
the intervention pharmacies increased by 204% in Kenya (1 trial,
106 pharmacies; RR 3.04, 95%CI 1.37 to 6.75: Analysis 1.1) and
41% in Indonesia (1 trial, 87 pharmacies; RR 1.41, 95%CI 1.03
to 1.93: Analysis 1.1); compared to control pharmacies. In Kenya
(Abuya 2009), correct prescription and dispensing of anti-malarial
drugs improved substantially (1 trial, 293 pharmacies; RR 8.76,
95%CI 0.94 to 81.81: Analysis 1.2). Using the GRADE approach
(Balshem 2011) we judged the certainty of evidence on the effects
of training on quality of care as moderate (Summary of findings
for the main comparison). Although the findings were consistent
across the studies, we downgraded the evidence because of a mod-
erate risk of bias in the included studies (Figure 3).
Regulation
In the ’regulationonly’ study, conducted in the LaoPeople’sDemo-
cratic Republic, the distribution and selling of registered phar-
maceutical products was regulated in order to protect consumers
against unfair practices (Stenson 2001). The study observed an
increase of 34% in the availability of essential materials for dis-
pensing and an increase of 19% in mean orderliness (including
the presence of advertisements, and storage of drugs in their orig-
inal packaging away from sunlight) in the intervention pharma-
cies compared to the control pharmacies. ”Information given to
customers increased from 35% to 51% and the mixing of dif-
ferent drugs in the same package went down from 17% to 9%.
The pharmacies in the active intervention districts showed greater
improvements for four of the six pharmacy indicators“ (Stenson
2001) . Using the GRADE approach (Balshem 2011), we judged
the certainty of the evidence on the effects of the regulatory inter-
ventions on quality of care as low (Summary of findings 2). Our
main concern with the evidence was the imprecision of the effect
estimate.
Multifaceted intervention
In the multi-faceted intervention studies (Chalker 2002; Chalker
2005; Chuc 2002), the interventions (regulation, training, and
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peer influence) were applied in a sequence, and the study design
does not permit separation of the effects of the different interven-
tions. The three studies provided inconsistent results regarding the
effect of the multiple interventions on quality of pharmacy prac-
tice; including the ability to ask questions, give advice, and pro-
vide appropriate treatment for four tracer conditions (acute res-
piratory conditions, malaria, diarrhoea, and sexually transmitted
infections). In one study conducted in Vietnam (Chalker 2002),
knowledge and reported practice among drug sellers improved
for three of the four tracer conditions in intervention pharmacies
compared to control pharmacies. The second study conducted in
Vietnam, (Chuc 2002), found that the intervention pharmacies
improved substantially in all tracer conditions compared to the
control pharmacies. Chalker 2005was conducted in bothVietnam
and Thailand and hadmixed results. Improvements were observed
in Vietnam in the dispensers’ behaviour for all tracer conditions,
but in Thailand improvements occurred in only one of the tracer
conditions. We judged the certainty of the evidence on the effects
of the multifaceted intervention as low (Summary of findings 3),
because of concerns regarding inconsistency of findings and high
risk of bias in the included studies.
Secondary outcomes
Two multifaceted intervention studies reported the cost of the
interventions (Chalker 2002; Chuc 2002). Chalker 2002 reported
the cost incurred for the three interventions in 30 pharmacies to
be USD 5700. The Chuc 2002 study reported that the costs of
treating four tracer conditions increased for both intervention and
control pharmacies.
No study reported data on equity, mortality, morbidity, adverse
effects, satisfaction, or attitudes.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Regulation compared to no regulation for improving quality of care
Population: Private for-prof it providers of healthcare services
Settings: Lao People’s Democrat ic Republic
Intervention: Regulat ion
Comparison: No regulat ion
Outcomes Impacts No of Participants
(studies)
Certainty of the evidence
(GRADE)
Quality of care Regulat ion may improve qual-
ity of care. The study ob-
served an increase of 34%
in the availability of essent ial
materials for dispensing and
an increase of 19%in mean or-
derliness (including the pres-
ence of advert isements, and
storage of drugs in their origi-
nal packaging away f rom sun-
light) in the intervent ion phar-
macies compared to the con-
trol pharmacies
115 pharmacies
(1 study)
⊕⊕©©
Low*
* We downgraded the certainty of the evidence by 2 points, because of a high risk of attrit ion bias and wide conf idence
intervals around the ef fect est imate, ranging f rom a large benef it to important harm
GRADE Working Group grades of evidence
High certainty: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate certainty: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and
may change the est imate.
Low certainty: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is
likely to change the est imate.
Very low certainty: We are very uncertain about the est imate
Training and regulation compared to no intervention for improving quality of care
Population: Private for-prof it providers of healthcare services
Settings: Thailand and Vietnam
Intervention: Training, regulat ion, and peer inf luence
Comparison: No intervent ion
Outcomes Impact No of Participants
(studies)
Certainty of the evidence
(GRADE)
Quality of care Training and regulat ion may
improve quality of care
379 pharmacies
(3 studies)
⊕⊕©©
Low*
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* We downgraded the certainty of evidence by 2 points because of a high risk of attrit ion bias and heterogeneity of
intervent ion ef fects. Two studies found that training, regulat ion, and peer inf luence may improve quality of care while the
third study found lit t le or no ef fects in the quality of care with the intervent ion
GRADE Working Group grades of evidence
High certainty: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate certainty: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and
may change the est imate.
Low certainty: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is
likely to change the est imate.
Very low certainty: We are very uncertain about the est imate.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
D I S C U S S I O N
Summary of main results
Our comprehensive search of the literature identified 20,177
records, from which six randomised controlled trials fulfilled our
inclusion criteria. In two studies in Kenya and Indonesia, theMin-
istry of Health offered private drug sellers short training sessions
on prescribing and dispensing drugs. These sellers were compared
to drug sellers who were not offered training. The studies sug-
gest that training probably improves the quality of healthcare ser-
vices. In one study in the Lao People’s Democratic Republic, the
Ministry of Health supervised private pharmacy services in cer-
tain districts over a three-month period, applied sanctions when
rules were broken, and offered information about areas needing
improvement. These districts were compared to districts without
this enhanced supervision. The study suggests that this enhanced
regulation may improve quality of care. In three studies in Viet-
nam and Thailand, private pharmacies in some districts received
educational visits as well as visits from pharmacy inspectors to en-
force regulations. These districts were compared to districts that
did not receive any visits. The studies suggest that these types of
visits may provide mixed results. The review did not find any eli-
gible study that assessed the effects of co-ordination on quality of
care.
Overall completeness and applicability of
evidence
Despite the large number of records obtained in our literature
search, only six studies with moderate to high risk of bias met
our inclusion criteria. All studies were conducted in Africa and
Asia; and the results may be applicable to low- andmiddle-income
countries in other continents.
Health worker availability in the public sector is a key barrier to
strengthening health systems in LMICs. Effective government in-
terventions to expand the coverage of private for-profit healthcare
providers and rationalise access to their services with that of public
sector providers could strengthen health systems in LMICs. How-
ever, countries considering the implementation of public stew-
ardship interventions need to assess the human and financial re-
source capacity of the public sector to properly supervise private
providers.
All the studies covered only services of private for-profit pharma-
cists. The findings may not be directly transferable to other cadres
of private healthcare providers. Therefore, there is a need for stud-
ies on other private sector components such as private hospitals,
physicians, midwives, nurses, and traditional healers.
There were no studies that reported data on equity, mortality,
morbidity, adverse effects, satisfaction, or attitudes. If training or
regulatory interventions are directed at providers that serve disad-
vantaged populations they could help to decrease inequity. How-
ever, intervention effects could vary across settings, for example
between rural and urban areas, because of the distribution of pri-
vate providers in these different areas. Expanding the coverage
of private for-profit providers could reduce inequity if, for exam-
ple, access to the private sector is available where access to the
public sector is limited. However, if private for-profit providers
are unavailable in underserved areas, expanding access to private
providers may increase inequity between urban and rural areas.
There was no rigorous evaluation of the cost implications of im-
plementing the interventions, thus this review does not provide
evidence on investment in private for-profit providers on quality
of care in low- and middle- income countries. The structure and
specific tasks associated with a particular public stewardship func-
tion will determine the costs. Given these uncertainties, imple-
mentation of public sector regulation, training or co-ordination
of private for-profit healthcare providers should be accompanied
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by a robust framework for monitoring the costs and impacts of
the interventions.
Much of the currently available literature on training and regu-
lation of private for-profit providers in low- and middle-income
countries is descriptive rather than evaluative, detailing experi-
ences that may have great potential without rigorously testing
their effectiveness (Berendes2011; Patouillard 2007;Waters 2003;
Wiysonge 2008).Well-designed studies evaluating public steward-
ship functions are therefore needed before these are implemented
on a large scale in low-income countries.
Certainty of the evidence
Using the GRADE approach, we judged the certainty of evidence
on the effects of training interventions on quality of care as moder-
ate; which implies that “further research is likely to have an impor-
tant impact on our confidence in the estimate of effect and is likely
to change the estimate”. We rated the certainty of evidence on
regulation and the multifaceted intervention as low, which means
that “further research is very likely to have an important impact on
our confidence in the estimate of effect and is likely to change the
estimate” (Balshem 2011). Our main concerns with the evidence
were limitations of the included studies, wide confidence intervals
around the effect estimates, and heterogeneity of intervention ef-
fects.
Potential biases in the review process
We minimised potential biases in the review process by adhering
to Cochrane guidelines (Higgins 2011). We conducted compre-
hensive searches without limiting the searches to a specific lan-
guage. Two authors independently assessed study eligibility, ex-
tracted data, and assessed the risk of bias in each included study.
Agreements and disagreements with other
studies or reviews
Despite the widespread availability of private healthcare services in
low- andmiddle-income countries, there is a shortage of systematic
reviews that have assessed interventions showing how governments
have worked with the private for-profit providers to achieve public
health goals (Brugha 1998; Levin 2011; Patouillard 2007; Peters
2004; Waters 2003). To the best of our knowledge, our review is
themost comprehensive andup-to-date assessment of the evidence
on the effects of training, regulation, and co-ordination of private-
for-profit health care in low- and middle-income countries.
In 2003 Hugh Waters and colleagues published a review that as-
sessed the evidence available concerning public sector efforts to
work with private health service providers and other components
of the private sector, in order to both improve the quality of
their services and to rationalise and expand their coverage (Waters
2003). The review focused on interventions aimed at regulating,
contracting, financing, social marketing, training, co-ordinating,
and informing private providers in low- and middle-income coun-
tries. The review authors searched Pubmed and Popline databases,
and reference lists of included articles, for both published and un-
published literature from1980 onwards. They included 42 studies
including six ‘controlled’ trials comparing results in two or more
groups; 10 studies with a pre-post evaluative component, but no
comparison group; four cross-sectional studies; and 22 descriptive
case studies. Waters 2003 found that although governments are
gaining experience in using the tools of contracting, regulating,
financial incentives, training, co-ordinating, and informing to in-
fluence the private sector, the evidence on the effectiveness of these
interventions remains weak.
In 2007 Edith Patouillard and co-workers published a related re-
view, which assessed the effectiveness of interventions on working
with the private for-profit sector to improve utilisation of quality
health services by the poor in low- and middle-income countries
(Patouillard 2007). Interventions of interest to the review authors
included socialmarketing, use of vouchers, pre-packaging of drugs,
franchising, training, regulation, accreditation, and contracting-
out. They conducted a comprehensive search of peer-reviewed and
grey literature for eligible studies; focusing on studies which eval-
uated the impact of interventions on utilisation or quality of ser-
vices, or both, and which provided information on the socioeco-
nomic status of the beneficiary populations. The review authors
identified 52 eligible studies; five provided data on the average
socioeconomic status of recipient communities and five provided
data on the distribution of benefits across socioeconomic groups.
Patouillard 2007 concluded that it is not possible to prove from
the available literature that private sector interventions benefit the
poor and improve equity. However, they argue that the fact that
many such interventions have operated successfully in relatively
poor settings indicates that the interventions do benefit the poor.
The authors went on to recommend that better evidence of the
equity impact of interventions working with the private sector is
needed for more robust conclusions to be drawn.
There are marked differences between these two previous reviews
(Patouillard 2007; Waters 2003) and the current systematic re-
view. Although the authors of the two previous reviews conducted
literature searches that were relatively comprehensive, they do not
explicitly say whether they undertook duplicate study selection
and data extraction and do not report reliable criteria for assessing
the risk of bias in included studies. They do not provide appro-
priate description of the characteristics of included studies and do
not seem to synthesise data from included studies using reliable
methods. In addition, much of the data reported in the reviews is
descriptive rather than evaluative, detailing experiences that may
have great potential without rigorously testing their effectiveness.
Most of the studies included in the reviews were not set up as re-
search projects (Patouillard 2007;Waters 2003). Furthermore, the
two reviews included studies in which the stewardship functions
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were carried out by the public sector as well as those in which
the functions were carried out by non-governmental organisations
(NGO). We acknowledge that while ultimately public steward-
ship is the responsibility of government, this does not mean all
stewardship functions have to be carried out by the public sector.
While we recognise the importance of private sector interventions
implemented by NGOs, their characteristics and incentives are
likely to differ from those implemented by government. We in-
cluded one study in our review (Abuya 2009), which was pub-
lished after publication of the two previous reviews (Patouillard
2007; Waters 2003).
To the best of our knowledge, our review is the most comprehen-
sive and up-to-date assessment of the evidence on the effects of
training, regulation, and co-ordination of private for-profit health-
care providers in low- and middle-income countries. Some recent
Cochrane reviews have assessed public stewardship interventions
not covered in our review; such as social marketing and franchis-
ing (Koehlmoos 2009), contracting (Lagarde 2009), and pay for
performance (Witter 2012). Koehlmoos 2009 did not find any
eligible studies that assessed the effects of social franchising on
access to, and the quality of, health services in low- and middle-
income countries. We are therefore uncertain about the effects of
social franchising as a public stewardship function. Lagarde 2009
examined the effects of contracting out and included three stud-
ies, all conducted in low- and middle-income countries. The re-
view found that contracting out services to non-state not-for-profit
providers may increase access to and utilisation of health services,
improve patient outcomes, and reduce household health expendi-
tures. None of the three included studies presented evidence on
whether contracting out was more effective than making a similar
investment in the public sector. Witter 2012 found nine studies
that assessed the effects of pay-for-performance schemes on the
provision of healthcare and health outcomes in low- and middle-
income countries. The review found that it is uncertain whether
pay-for-performance improves provider performance, the utilisa-
tion of services, patient outcomes or resource use in low- and mid-
dle-income countries. Unintended effects of pay-for-performance
schemes might include adverse selection (for example, excluding
high-risk people from care in order to obtain better performance),
deception (i.e. inaccurate or false reporting), and distortion (i.e.
ignoring important tasks that are not rewarded with incentives).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review provides different levels of strength for the currently
available evidence on the effectiveness of the three public steward-
ship interventions. The finding that training probably improves
quality of care implies that monitoring of the impact is likely to be
needed and an impact evaluation may be warranted if government
training of private for-profit providers is implemented in low- and
middle-income countries. The low certainty of the evidence for
regulation implies that an impact evaluation is warranted if gov-
ernment regulation of private for-profit providers is implemented
in low- and middle-income countries. We found no studies on the
effects of government co-ordination of private providers.
Implications for research
Rigorous evaluations of the interventions assessed in this review
(as well as other public stewardship interventions) should assess
cost implications, patient outcomes, and impacts on equity; in
addition to quality of care. Given that there was no evidence on
the impact of the interventions on equity, the challenge for the
future is to design evaluations and report results in ways that can
assess equity clearly, and indicate how equity can be enhanced.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Abuya 2009
Methods Cluster-randomised trial conducted in 3 districts in Kenya from 2002-2005
Participants Number enrolled: 10 clusters (sub-districts) with a total of 140 functional anti-malarial
medicine ’shops’
Study population: 10 divisions (clusters) in 3 rural districts inKenya (i.e. Kwale,Makueni
and Busia ) with divisions as unit of randomisation in Kenya
Inclusion criteria: themain sellers in outlets stocking anti-malarialmedicines. The eligible
outlets had to be relatively stable (on the basis of local knowledge)
Exclusion criteria: non-functional anti-malarial medicine outlets
Withdrawals and exclusions: in Kwale district, 24% of trainees changed business or
closed their outlets. In Makueni and Busia districts, 4% and 5% of trainees respectively
closed their outlets within 6-8 months after training
Interventions Intervention: 5 divisions (clusters) with 60 functional medicine outlets were allocated to
the intervention group. In total, 122 private medical retailers were trained in Kwale, 79
in Busia, and 247 in Makueni districts
Duration: the intervention consisted of 2-day training workshops at local venues
Who delivered the intervention: Kenya’s Ministry of Health
Description: the training covered signs of simple and severe malaria; malaria treatment
and prevention; drug resistance; referral practices; storage and expiry of medicines; and
communication skills
Comparison: no training was conducted in 5 ’control’ divisions (clusters) with 80 outlets
Outcomes Retailers’ knowledge on the treatment of childhood fevers; recommended amodiaquine
adequately
Surrogate clients were used to pose as patients and retail audits were used to collect
information on the outlets and retailers
Notes The study was approved by the Kenya National Scientific Steering and Ethical Research
Committees and the WHO Secretariat Committee on Research Involving Human Sub-
jects (SCRIHS)
A cost-effectiveness study of the intervention inKenya suggested that, although the initial
cost of setting such programmes is high, the annual running costs could be contained
within a typical district budget. In total, USD 5202.00 and USD 5882.00 were released
to Kwale and Makueni districts respectively, for the implementation of the programmes
in the setup year. The programme in Busia district was implemented with funds from
UNICEF, with a total of USD5838 allocated
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description
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Abuya 2009 (Continued)
Allocation concealment (selection bias) Unclear risk No description
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Surrogate clients, fieldworkers posed as
clients seeking care from a provider who
was unaware of the clients’ identity
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Surrogate clients, fieldworkers posed as
clients seeking care from a provider who
was unaware of their identity
Incomplete outcome data (attrition bias)
All outcomes
High risk 4% and 24% of trained outlets closed
within 6-8 months of training
Selective reporting (reporting bias) Unclear risk No description
Other bias Low risk No evidence of other sources of bias
Similar baseline characteristics Low risk The District Health Management Team in
each district identified divisions they con-
sidered similar in characteristics
Similar baseline outcome measures Unclear risk No description
Reliable primary outcome measures Unclear risk No description
Adequate protection against contamina-
tion
High risk It is possible that there was some degree
of contamination in Busia district, a sug-
gestion supported by the District Health
Management Team report that the district
had experienced almost complete coverage
with PMR programmes at the time of the
evaluation, leaving only one division as the
control
Chalker 2002
Methods Cluster-randomised trial conducted in Hanoi, Vietnam, conducted from May 1998-
September 1999
Participants Number enrolled: 34 paired pharmacies in urban Hanoi
Study population: private pharmacies registered in the urban area of Hanoi
Inclusion criteria: private registered pharmacies in urban Hanoi
Exclusion criteria: pharmacies outside hospitals and not mainly wholesalers
Withdrawal and exclusions: in the course of the study, 4 pharmacies closed and 1 refused
to take part in the third intervention. No post-intervention interviews were taken from
4 intervention and 4 control pharmacies as they were closed early before the Vietnamese
New Year holidays. These gave 22 matched pairs
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Chalker 2002 (Continued)
Interventions Intervention: regulatory enforcement, face-to-face education, and peer influence. The
three interventions were implemented sequentially in 22 pharmacies
Duration: each intervention lasted 3 months, with a gap of 4 months before the next
intervention
Who delivered the intervention: the Hanoi Health Bureau and the Hanoi Pharmacy
Association
Description:
• for the regulatory intervention, 4 inspectors of the Hanoi Health Bureau were
trained to undertake the inspection. In pairs the inspectors visited the intervention
pharmacies twice, a month apart
• for the face-to-face education intervention, each intervention pharmacy was
visited twice by 2 people who conducted face to- face education sessions with all staff
present. Each session lasted about 45 minutes and included both written and verbal
information
• For the peer influence intervention, a 1-day seminar was held with the 5 group
leaders and representatives of the Hanoi Pharmacy Association
Comparison: 22 pharmacies with no intervention
Outcomes Knowledge and reported change in practice for correct management of tracer conditions
Notes The cost for the 3 interventions was approximately USD 5700.00 for 30 pharmacies
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description
Allocation concealment (selection bias) Unclear risk No description
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No description
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No description
Selective reporting (reporting bias) Unclear risk No description
Other bias Low risk Failure to interview people from 4 inter-
vention and 4 control pharmacies after the
interventions may have caused a bias in re-
sults, but this is unlikely because of the
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Chalker 2002 (Continued)
equivalent numbers between intervention
and control
Similar baseline characteristics Low risk There was matching of pharmacies to en-
sure similar baseline characteristics
Similar baseline outcome measures Low risk There was a slight difference in the out-
come measures at baseline level which was
not statistically significant
Reliable primary outcome measures Unclear risk No description
Adequate protection against contamina-
tion
Unclear risk No description
Chalker 2005
Methods Randomised trial conducted in Hanoi (Vietnam) and Bangkok (Thailand) from June
1998-September 1999
Participants Number enrolled: 68 pharmacies in Hanoi and 78 pharmacies in Bangkok
Study population: private registered pharmacies in Hanoi and Bangkok
Inclusion criteria: private pharmacies in Hanoi and Bangkok
Withdrawals and exclusions: in Bangkok 1 intervention pharmacy and 2 control phar-
macies closed down and 3 of each were missed in at least one of the simulated clients’
round of visits. In Hanoi 1 intervention and 3 control pharmacies closed, 1 interven-
tion pharmacy refused to continue, and 4 intervention and 4 control pharmacies had
incomplete data for different rounds of client visits
Interventions Intervention: enforcement of regulations, education, and peer review in 34 pharmacies
in Hanoi and 39 pharmacies in Bangkok
Duration: each intervention lasted 3 months, with a gap of 4 months before the next
intervention
Who delivered the intervention: the Hanoi Provincial Health Bureau, Hanoi Pharmacy
Association,HanoiMedical University, and theHanoi College of Pharmacy. InBangkok,
the interventionswere delivered by theHealth SystemResearch Institute, Chulalongkorn
University, and the Community Pharmacy Association
Description
• Regulation: in Hanoi, the intervention pharmacies were visited twice by 2
inspectors. A summary of the regulations on prescription-only medicine, a letter from
the provincial health bureau, and an example of good labelling were handed out to
each pharmacy. In Bangkok, the enforcement of regulation was performed by 6
inspectors. The inspectors checked the availability of steroids and steroid prescriptions
(if the drug was found) and gave instructions to the seller on the respective regulations.
A warning was given about the consequences of violation of the regulations
• Education: in Hanoi, each pharmacy received two 45-minute educational visits by
a pair of senior researchers using both written and verbal information. In Bangkok, the
educational intervention was performed in 3 groups. The pharmacy owners and the
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Chalker 2005 (Continued)
pharmacy assistants were invited to a 2-day seminar
• Peer review: the intervention pharmacies in Hanoi were divided into 5 area groups
with 5-6 pharmacies in each. Each of the 5 area groups held 5 meetings averaging 1
every second week. In Bangkok, prospective peer facilitators were identified among the
participants. The researchers initiated a group by visiting these 4-5 active drugstores in
each district and introducing the concept of peer groups for drugstore staff
Comparison: no intervention on 34 control pharmacies in Hanoi and 39 control phar-
macies in Bangkok
Outcomes Change in the dispensing practices of antibiotics in Hanoi and Bangkok
Notes The study had ethical approval from the Karolinska Institute as well as the Ministries of
Health in Vietnam and Thailand
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description
Allocation concealment (selection bias) Unclear risk No description
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No description
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description
Incomplete outcome data (attrition bias)
All outcomes
High risk In Bangkok 1 intervention pharmacy and 2
control pharmacies closed down, and 3 of
eachweremissed in at least one of the simu-
lated clients’ visits. InHanoi 1 intervention
and 3 control pharmacies closed, 1 inter-
vention pharmacy refused to continue and
4 intervention and 4 control pharmacies
had incomplete data for different rounds of
client visits
Selective reporting (reporting bias) Unclear risk No description
Other bias Low risk The study appears to be free of other biases
Similar baseline characteristics Low risk Some basic characteristics (i.e. turnover,
staff numbers and qualifications) were not
possible to judge from the simulated clients’
visit. However, the random selection en-
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Chalker 2005 (Continued)
sured comparability between intervention
and control pharmacies
Similar baseline outcome measures Low risk There were no significant differences in the
outcome measures at baseline at intra-city
level but there was a difference in the base-
line knowledge at inter-city levels
Reliable primary outcome measures Unclear risk No description
Adequate protection against contamina-
tion
Unclear risk No description
Chuc 2002
Methods Cluster-randomised controlled trial conducted from October 1997-January 2000 in
Hanoi, Vietnam
Participants Number enrolled: 34 pairs of private pharmacies
Study population: 34 pairs of private pharmacies in Hanoi randomly selected according
to the following matching criteria:
• turnover: high, medium, or low according to district inspectors;
• whether or not the pharmacist was the licence holder;
• whether or not the pharmacy was close to a hospital; and
• located in a different ward or more than 150 meters from all other pharmacies
selected
Inclusion criteria: private pharmacies in the study area
Exclusion criteria: pharmacies located inside a hospital or that were mainly wholesalers
were excluded
Withdrawals and exclusions: 4 pharmacies were excluded because of irregular opening
hours. As a consequence, the other pharmacy in each pair was also excluded as the results
were analysed in pairs
Interventions Intervention: regulatory enforcement, educational intervention, and peer review
Duration: each intervention lasted 3 months, with a gap of 4 months before the next
intervention
Who delivered the intervention: Hanoi Bureau Health and Hanoi Pharmacy Association
Description
• For regulation: 4 inspectors from the Hanoi Health Bureau were trained to cover
these areas of inspection. In pairs they visited the intervention pharmacies twice with
an interval of 1 month
• For education: 2 senior research team members and 2 clinicians conducted the
intervention. Each intervention pharmacy received two 45-min face-to-face
educational sessions
• Peer review: 5 group leaders conducted a 1-day seminar where the research group
informed about the peer influence strategy and reviewed case management of the 4
tracer conditions. 3 meetings were held during 3 months where the participants
presented and discussed their records
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Chuc 2002 (Continued)
Comparison: no intervention
Outcomes Effect of multi-component intervention using tracer conditions i.e. correct symptomatic
treatment of sexually transmitted disease
Notes The estimated total cost of the interventions was approximately USD 5700.00
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description
Allocation concealment (selection bias) Unclear risk No description
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No description
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No description
Incomplete outcome data (attrition bias)
All outcomes
High risk 4 pharmacies were excluded because of ir-
regular opening hours. As a consequence,
the other pharmacy in each pair was also ex-
cluded as the results were analysed in pairs
Selective reporting (reporting bias) Unclear risk No description
Other bias Low risk The study appears to be free of other
sources of bias
Similar baseline characteristics Low risk The pharmacies paired to ensure a similar
composition for intervention and control
groups
Similar baseline outcome measures Unclear risk No description
Reliable primary outcome measures Unclear risk No description
Adequate protection against contamina-
tion
Low risk To prevent the client’s individual behaviour
fromaffecting the pharmacy staff, all clients
were trained to act in a reproducible way,
and they were not informed about which
pharmacies belonged to the intervention or
control groups
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Ross-Degnan 1996
Methods Non-randomised controlled trial conducted in Kenya
Randomised controlled trial conducted in IndonesiaDate not stated
Participants Number enrolled: 112 pharmacies in Kenya and 87 pharmacies in Indonesia
Study population
• In Kenya, the study was done in Nairobi, Nakuru and Mombasa
• In Indonesia the pharmacies were selected from Jakarta and the neighbouring
communities of Bogor, Tangerang, and Bekasi
Inclusion criteria: private pharmacy in the study area
Withdrawals and exclusions: Four pharmacies in Kenya and five pharmacies in Indonesia
were excluded because the analyses were limited to the outcomes that were measured
both before and after the intervention
Interventions Intervention: training in 82 pharmacies in Kenya and 43 pharmacies in Indonesia
Duration: 1 day in Kenya and 2 days in Indonesia
Who delivered the intervention: Control of Diarrhoea Diseases (CDD) programmes in
the Ministry of Health
Description: in both countries, the intervention began with brief one-on-one meetings
with pharmacists/pharmacy owners discussing key training messages and ways to deal
with perceived barriers to practice recommendations, followed by training of all counter
attendants in group sessions of 5-10 attendees organised close to their pharmacies. To
measure changes in treatment practice, all pharmacies included in the study in both
countries were visited by surrogate patients
Comparison: the no-training control group consisted of 25 pharmacies in Kenya and 44
pharmacies in Indonesia
Outcomes Proportion of cases who received oral rehydration salts (ORS)
Notes
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description
Allocation concealment (selection bias) Unclear risk No description
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Trainees and pharmacy owners were not in-
formed that the sales practices in their phar-
macies would be evaluated
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcomes were assessed by surrogate pa-
tients who were blind to the purpose of the
study, and to the study or control status of
the pharmacies
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Ross-Degnan 1996 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No description
Selective reporting (reporting bias) Unclear risk No description
Other bias Low risk The study appears to be free of other
sources of bias
Similar baseline characteristics Low risk There were similar baseline characteristics
Similar baseline outcome measures Unclear risk No description
Reliable primary outcome measures Unclear risk No description
Adequate protection against contamina-
tion
Unclear risk No description
Stenson 2001
Methods Randomised controlled trial conducted from June 1997 to March 1999 in the Lao
People’s Democratic Republic (Lao P.D.R.)
Participants Number enrolled: 115 pharmacies
Study population: the study was based on licensed private pharmacies in Savannakhet
province, Lao P.D.R. All pharmacies except 2 belonged to class 3, the lowest class of
licensed pharmacies, where the licensee does not have to be a pharmacist or an assistant
pharmacist. Most of them had a nursing background
Inclusion criteria: operating pharmacy within the province
Exclusion criteria: the pharmacies that were missed in the (post-intervention analysis)
were excluded from the analysis
Withdrawals and exclusions: 14 pharmacies were missed during study and the reasons
for missing pharmacies were mortality among drug sellers or that the pharmacy had
moved or was closed for family reasons
Interventions Intervention: active regulation in 46 pharmacies
Duration: One and half years
Who delivered the intervention: Ministry of Health with assistance from UNICEF
Description: the regulatory intervention involved three month’s intensive supervision of
the quality of pharmacy services, applying sanctions when rules were violated, and pro-
viding up-to-date regulatory documents and information about particular areas need-
ing improvements. The study compared districts with active regulation to districts with
regular care
Comparison: 92 control pharmacies received regular care
Outcomes Change of the quality of private pharmacy practice (pharmacy indicators)
Notes
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Stenson 2001 (Continued)
Risk of bias Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description
Allocation concealment (selection bias) Unclear risk No description
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk It was not possible to make the study
blinded with regard to the main interven-
tion vehicle, the research assistant. It could
not be established to what extent the drug
sellers had any active knowledge of the
study objectives
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The district pharmacists who were active
partners in the research team and partici-
pated in the sampling procedures and as-
sessing the outcome were also aware of the
scope of the intervention
Incomplete outcome data (attrition bias)
All outcomes
High risk 14 pharmacies were missed during the
study and the reasons for missing pharma-
cies were mortality among drug sellers or
that the pharmacy hadmoved or was closed
for family reasons
Selective reporting (reporting bias) Unclear risk No description
Other bias Low risk The study appears to be free of other
sources of bias
Similar baseline characteristics Low risk There were similar baseline characteristics
i.e. income levels and literacy
Similar baseline outcome measures Unclear risk No description
Reliable primary outcome measures Unclear risk No description
Adequate protection against contamina-
tion
Unclear risk No description
UNICEF: The United Nations Children’s Fund
WHO: World Health Organization
34Public stewardship of private for-profit healthcare providers in low- and middle-income countries (Review)
Copyright © 2016 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Akol 2014 This was a cross-sectional study
Akoria 2008 This was a controlled before-after study but the participants were not private-for-profit providers
Ali 2011 This was a cross-sectional study
Ali 2012 This was a cross-sectional survey
Andrianasolo 2012 This was a prospective descriptive study
Bhat 1996 This was a cross-sectional study
Bin 2013 A controlled before-after study with single unit for intervention and control arms
Bojalil 1999 This was a controlled before-after study and the participants were described as private providers, but it is not
clear if these were for-profit or not-for-profit healthcare providers
Chakraborty 2000 This was an uncontrolled before-after study design
Contiades 2007 This was a descriptive study
Dholakia 2013 This was a descriptive study of an intervention administered through a non-governmental organisation
Farsi 1999 This was a randomised trial but its not clear who delivered the intervention
Fernandes 2009 This was a before-after study and the intervention was undertaken among school children and not healthcare
providers
Goodman 2007 This was a cross-sectional study
Grundy 2010 This was a cross-sectional study
Guiscafre 2001 This was a cross-sectional study
Harrison 2000 This was a randomised trial; but the intervention was not implemented by the public sector, and participants
were not private-for-profit providers
Hongoro 2000 This was a cross-sectional study
Hulda 2015 A controlled before-after study with single unit for intervention and control arms
Kangwana 2011 This was a randomised trial; but the intervention was not implemented by the public sector, and participants
were not private-for-profit providers
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Khan 2006 This was a cross-sectional study
Kumaranayake 2000 This was a cross-sectional study
Maiga 2010 This was a cross-sectional study
Marsh 2004 This was a cross-sectional study
Minh 2013 This was a cross-sectional study
Morris 2013 This was an uncontrolled before-after study
Murugesan 2009 This was a cross-sectional study
Nsimba 2007 This was a cross-sectional study
Obua 2004 This was a controlled before-after study, but it is not clear whether the participants were private not-for-profit
or private for-profit providers
Okonofua 2003 This was a randomised trial, but the intervention was offered by the private sector rather than the public
sector
Osterholt 2009 This was a time series study, with one measure before and twomeasures after introduction of the intervention.
This does not meet our criteria for eligible interrupted time series studies i.e. at least three measurements
before and after introducing the intervention
Rutta 2011 This was a descriptive pilot study
Rutta 2015 This was a prospective descriptive study
Stenson 2001b This was a cross-sectional study
Syhakhang 2001 This was a cross-sectional study
Tavrow 2003 This was a cross-sectional study
Tumwikirize 2004 This was a non-randomised trial but it is not clear who offered the intervention
Ward 2013 This was an uncontrolled before-after study
Willey 2014 The intervention was not administered on participants
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Characteristics of studies awaiting assessment [ordered by study ID]
Ansah 2015
Methods Cluster-randomised trial in Dangme West, a poor rural district of Ghana, from August 2011-January 2013
Participants Drug sellers in registered chemical shops within 24 community clusters
Interventions Intervention: training on malaria rapid diagnostic tests and appropriate malaria case management
Comparison: standard care
Outcomes Change of practice in malaria diagnosis and antimalarial prescription
Notes
El-Khoury 2015
Methods Randomised trial in two regions in Jordan, between January 2012 and January 2013
Participants 267 private doctors who provide family planning services in Amman and Zarqa regions in Jordan
Interventions Intervention: evidence-based medicine seminar on depot medroxy progesterone acetate and two educational visits to
reinforce the messages from the seminar
Comparison: invited to the seminar, but were not offered the educational visits
Outcomes Providers’ knowledge, attitudes, practices regarding depot medroxy progesterone acetate
Notes
Kafle 2013
Methods Randomised trial in three geographical regions of Nepal
Participants 342 drug sellers in private pharmacies in 12 districts in Nepal
Interventions Intervention 1: mailed printed educational materials followed by mailed feedback
Intervention 2: small group training followed by feedback
Intervention 3: small group training only
Comparison group: no intervention
Outcomes Quality of management of acute respiratory infections and diarrhoea in children, and anaemia in pregnancy
Notes
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Mbonye 2015
Methods Cluster-randomised trial in Mukono district, central Uganda, from October 2010-July 2012
Participants Drug sellers in 20 geographical clusters of registered drug shops
Interventions Intervention: training to perform malaria rapid diagnostic tests to inform malaria case management
Comparison: current practice of presumptive clinical diagnosis and treatment of fever
Outcomes Proportion of patients receiving appropriate treatment with artemisinin-based combination therapy
Notes
Santa-Ana-Tellez 2016
Methods Interrupted time series among private sectors in Mexico and Brazil from the first quarter of 2007 to the first quarter
of 2013
Participants Described as private providers
Interventions Over-the-counter antibiotic sales restrictions
Outcomes Changes in the use of non-steroidal anti-inflammatory drugs, non-opioid analgesics, and cough and cold medicines
and their relation with the use of antibiotics
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. Training
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Quality of care 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 RCT studies 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Non RCT studies 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Quality of care 1 Odds Ratio (Fixed, 95% CI) Totals not selected
Analysis 1.1. Comparison 1 Training, Outcome 1 Quality of care.
Review: Public stewardship of private for-profit healthcare providers in low- and middle-income countries
Comparison: 1 Training
Outcome: 1 Quality of care
Study or subgroup Training No-training Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 RCT studies
Ross-Degnan 1996 33/43 24/44 1.41 [ 1.03, 1.93 ]
2 Non RCT studies
Ross-Degnan 1996 52/82 5/24 3.04 [ 1.37, 6.75 ]
0.01 0.1 1 10 100
Favours no-training Favours training
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Analysis 1.2. Comparison 1 Training, Outcome 2 Quality of care.
Review: Public stewardship of private for-profit healthcare providers in low- and middle-income countries
Comparison: 1 Training
Outcome: 2 Quality of care
Study or subgroup log [Odds Ratio] Odds Ratio Odds Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
Abuya 2009 2.17 (1.14) 8.76 [ 0.94, 81.81 ]
0.01 0.1 1 10 100
Favours no-training Favours training
A P P E N D I C E S
Appendix 1. Search strategies
CDSR and CENTRAL, Cochrane Library
ID Search Hits
#1 MeSH descriptor: [Public-Private Sector Partnerships] this
term only
8
#2 MeSH descriptor: [Private Sector] this term only 41
#3 MeSH descriptor: [Private Practice] this term only 84
#4 MeSH descriptor: [Hospitals, Private] this term only 16
#5 MeSH descriptor: [Privatization] this term only 2
#6 privat*:ti,ab 2190
#7 #2 or #3 or #4 or #5 or #6 2245
#8 MeSH descriptor: [Public Sector] this term only 51
#9 MeSH descriptor: [Public Policy] this term only 53
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(Continued)
#10 MeSH descriptor: [Health Policy] this term only 338
#11 [mh ˆ”state medicine“] 460
#12 MeSH descriptor: [State Dentistry] this term only 7
#13 MeSH descriptor: [Health Care Reform] this term only 34
#14 MeSH descriptor: [Health Planning] this term only 64
#15 MeSH descriptor: [Social Control, Formal] this term only 30
#16 MeSH descriptor: [Law Enforcement] this term only 32
#17 MeSH descriptor: [Government] 2 tree(s) exploded 813
#18 MeSH descriptor: [Government Programs] this term only 30
#19 MeSH descriptor: [Government Regulation] this term only 14
#20 MeSH descriptor: [Facility Regulation and Control] this term
only
3
#21 MeSH descriptor: [Policy Making] this term only 47
#22 MeSH descriptor: [Jurisprudence] this term only 75
#23 MeSH descriptor: [Mandatory Reporting] this term only 10
#24 MeSH descriptor: [Politics] this term only 40
#25 MeSH descriptor: [Legislation as Topic] this term only 8
#26 MeSH descriptor: [Legislation, Hospital] this term only 0
#27 MeSH descriptor: [Legislation, Medical] this term only 5
#28 MeSH descriptor: [Legislation, Nursing] this term only 0
#29 MeSH descriptor: [Legislation, Pharmacy] this term only 5
#30 MeSH descriptor: [Legislation, Drug] this term only 15
#31 [mh ˆ”legislation, dental“] 0
41Public stewardship of private for-profit healthcare providers in low- and middle-income countries (Review)
Copyright © 2016 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
(Continued)
#32 (public* or stewardship* or governance or governing or coordi-
nat* or co next ordinat* or legislat* or regulat* or government*
or law or laws or act or acts or policy or policies or politics or
reform* or control* or supervis* or monitor*):ti,ab
356001
#33 #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16
or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or
#25 or #26 or #27 or #28 or #29 or #30 or #31 or #32
357053
#34 MeSHdescriptor: [Physician’s Practice Patterns] this term only 1104
#35 MeSH descriptor: [Nurse’s Practice Patterns] this term only 62
#36 MeSH descriptor: [Dentist’s Practice Patterns] this term only 20
#37 MeSH descriptor: [Health Knowledge, Attitudes, Practice]
this term only
3833
#38 MeSH descriptor: [Malpractice] this term only 13
#39 MeSH descriptor: [Professional Impairment] this term only 0
#40 MeSH descriptor: [Physician Impairment] this term only 4
#41 MeSH descriptor: [Medical Errors] this term only 119
#42 MeSH descriptor: [Diagnostic Errors] this term only 258
#43 MeSH descriptor: [Professional Competence] this term only 211
#44 [mh ˆ”medication errors“] 228
#45 [mh ˆ”clinical competence“] 1999
#46 (competence or practice next pattern* or malpractice or mal
next practice or error*):ti,ab
9019
#47 #34 or #35 or #36 or #37 or #38 or #39 or #40 or #41 or #
42 or #43 or #44 or #45 or #46
15853
#48 MeSH descriptor: [Education] this term only 498
#49 MeSH descriptor: [Competency-Based Education] this term
only
67
#50 MeSHdescriptor: [Education, PublicHealth Professional] this
term only
3
42Public stewardship of private for-profit healthcare providers in low- and middle-income countries (Review)
Copyright © 2016 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The
Cochrane Collaboration.
(Continued)
#51 MeSH descriptor: [Education, Medical] this term only 300
#52 MeSHdescriptor: [Education,Medical, Continuing] this term
only
638
#53 MeSH descriptor: [Education, Nursing] this term only 117
#54 MeSHdescriptor: [Education,Nursing,Continuing] this term
only
249
#55 MeSH descriptor: [Education, Dental] this term only 110
#56 MeSH descriptor: [Education, Dental, Continuing] this term
only
17
#57 MeSH descriptor: [Education, Pharmacy] this term only 36
#58 [mh ˆ”education, pharmacy, continuing“] 27
#59 (educat* or train or training or trained or colloquium* or con-
ference* or course* or lecture* or meeting* or seminar* or sup-
port* or symposi* or workshop*):ti,ab
144494
#60 #48 or #49 or #50 or #51 or #52 or #53 or #54 or #55 or #
56 or #57 or #58 or #59
144875
#61 MeSH descriptor: [Delivery of Health Care] this term only 751
#62 MeSH descriptor: [Quality of Health Care] this term only 933
#63 MeSH descriptor: [Quality Assurance, Health Care] this term
only
741
#64 MeSH descriptor: [Quality Improvement] this term only 216
#65 MeSH descriptor: [Total QualityManagement] this term only 172
#66 MeSH descriptor: [Outcome and Process Assessment (Health
Care)] this term only
2034
#67 MeSH descriptor: [Outcome Assessment (Health Care)] this
term only
5357
#68 MeSH descriptor: [Process Assessment (Health Care)] this
term only
129
#69 MeSH descriptor: [Guideline Adherence] this term only 748
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#70 MeSH descriptor: [Benchmarking] this term only 100
#71 MeSH descriptor: [Standard of Care] this term only 91
#72 [mh ˆ”reference standards“] 357
#73 (best next practice or quality or standard* or benchmark* or
adherence or requirement*):ti,ab
129505
#74 #61 or #62 or #63 or #64 or #65 or #66 or #67 or #68 or #
69 or #70 or #71 or #72 or #73
136459
#75 (Africa or Asia or Caribbean or ”West Indies“ or ”South Amer-
ica“ or ”Latin America“ or ”Central America“):ti,ab,kw
5159
#76 (Afghanistan or Albania or Algeria or Angola or Antigua or
Barbuda or Argentina or Armenia or Armenian or Aruba or
Azerbaijan or Bahrain or Bangladesh or Barbados or Benin or
Byelarus or Byelorussian or Belarus or Belorussian or Belorus-
sia or Belize or Bhutan or Bolivia or Bosnia or Herzegovina
or Hercegovina or Botswana or Brasil or Brazil or Bulgaria or
”Burkina Faso“ or ”Burkina Fasso“ or ”Upper Volta“ or Bu-
rundi or Urundi or Cambodia or ”Khmer Republic“ or Kam-
puchea or Cameroon or Cameroons or Cameron or Camerons
or ”Cape Verde“ or ”Central African Republic“ or Chad or
Chile or China or Colombia or Comoros or ”Comoro Islands“
or Comores or Mayotte or Congo or Zaire or ”Costa Rica“ or
”Cote d’Ivoire“ or ”Ivory Coast“ or Croatia or Cuba or Cyprus
or Czechoslovakia or ”Czech Republic“ or Slovakia or ”Slovak
Republic“):ti,ab,kw
10175
#77 (Djibouti or ”French Somaliland“ or Dominica or ”Domini-
can Republic“ or ”East Timor“ or ”East Timur“ or ”Timor
Leste“ or Ecuador or Egypt or ”United Arab Republic“ or ”El
Salvador“ or Eritrea or Estonia or Ethiopia or Fiji or Gabon
or ”Gabonese Republic“ or Gambia or Gaza or Georgia or
Georgian or Ghana or ”Gold Coast“ or Greece or Grenada or
Guatemala or Guinea or Guam or Guiana or Guyana or Haiti
or Honduras or Hungary or India or Maldives or Indonesia
or Iran or Iraq or ”Isle of Man“ or Jamaica or Jordan or Kaza-
khstan or Kazakh or Kenya or Kiribati or Korea or Kosovo
or Kyrgyzstan or Kirghizia or ”Kyrgyz Republic“ or Kirghiz
or Kirgizstan or ”Lao PDR“ or Laos or Latvia or Lebanon or
Lesotho or Basutoland or Liberia or Libya or Lithuania):ti,ab,
kw
12314
#78 (Macedonia or Madagascar or ”Malagasy Republic“ or
Malaysia or Malaya or Malay or Sabah or Sarawak or Malawi
or Nyasaland orMali orMalta or ”Marshall Islands“ orMauri-
5924
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tania or Mauritius or ”Agalega Islands“ or Mexico or Microne-
sia or ”Middle East“ or Moldova orMoldovia or Moldovian or
Mongolia or Montenegro or Morocco or Ifni or Mozambique
or Myanmar or Myanma or Burma or Namibia or Nepal or
”Netherlands Antilles“ or ”New Caledonia“ or Nicaragua or
Niger or Nigeria or ”Northern Mariana Islands“ or Oman or
Muscat or Pakistan or Palau or Palestine or Panama or Paraguay
or Peru or Philippines or Philipines or Phillipines or Phillip-
pines or Poland or Portugal or ”Puerto Rico“):ti,ab,kw
#79 (Romania or Rumania or Roumania or Russia or Russian or
Rwanda or Ruanda or ”Saint Kitts“ or ”St Kitts“ or Nevis or
”Saint Lucia“ or ”St Lucia“ or ”Saint Vincent“ or ”St Vincent“
or Grenadines or Samoa or ”Samoan Islands“ or ”Navigator Is-
land“ or ”Navigator Islands“ or ”Sao Tome“ or ”Saudi Arabia“
or Senegal or Serbia or Montenegro or Seychelles or ”Sierra
Leone“ or Slovenia or ”Sri Lanka“ or Ceylon or ”Solomon Is-
lands“ or Somalia or Sudan or Suriname or Surinam or Swazi-
land or Syria or Tajikistan or Tadzhikistan or Tadjikistan or
Tadzhik or Tanzania or Thailand or Togo or ”Togolese Repub-
lic“ or Tonga or Trinidad or Tobago or Tunisia or Turkey or
Turkmenistan or Turkmen or Uganda or Ukraine or Uruguay
or USSR or ”Soviet Union“ or ”Union of Soviet Socialist Re-
publics“ or Uzbekistan or Uzbek or Vanuatu or ”New He-
brides“ or Venezuela or Vietnam or ”Viet Nam“ or ”West
Bank“ or Yemen or Yugoslavia or Zambia or Zimbabwe or
Rhodesia):ti,ab,kw
7359
#80 (developing or less* next developed or ”under developed“ or
underdeveloped or ”middle income“ or low* next income or
underserved or ”under served“ or deprived or poor*) next
(countr* or nation* or population* or world):ti,ab,kw
3266
#81 (developing or less* next developed or ”under developed“ or
underdeveloped or ”middle income“ or low* next income) next
(economy or economies):ti,ab,kw
20
#82 low* next (gdp or gnp or ”gross domestic“ or ”gross national“)
:ti,ab,kw
31
#83 (low near/3 middle near/3 countr*):ti,ab,kw 293
#84 (lmic or lmics or ”third world“ or ”lami country“ or ”lami
countries“):ti,ab,kw
75
#85 (”transitional country“ or ”transitional countries“):ti,ab,kw 2
#86 #75 or #76 or #77 or #78 or #79 or #80 or #81 or #82 or #
83 or #84 or #85
38271
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#87 #1 and #86 3
#88 #7 and #33 and #86 190
#89 #7 and #47 and #86 20
#90 #7 and #60 and #86 108
#91 #7 and #74 and #86 104
#92 #87or #88or #89or #90or #91 inCochraneReviews (Reviews
and Protocols)
23
#93 #87 or #88 or #89 or #90 or #91 in Trials 164
DARE and HTA, Cochrane Library
ID Search Hits
#1 MeSH descriptor: [Public-Private Sector Partnerships] this
term only
8
#2 MeSH descriptor: [Private Sector] this term only 41
#3 MeSH descriptor: [Private Practice] this term only 84
#4 MeSH descriptor: [Hospitals, Private] this term only 16
#5 MeSH descriptor: [Privatization] this term only 2
#6 privat* 4370
#7 #2 or #3 or #4 or #5 or #6 4370
#8 MeSH descriptor: [Public Sector] this term only 51
#9 MeSH descriptor: [Public Policy] this term only 53
#10 MeSH descriptor: [Health Policy] this term only 338
#11 [mh ˆ”state medicine“] 460
#12 MeSH descriptor: [State Dentistry] this term only 7
#13 MeSH descriptor: [Health Care Reform] this term only 34
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#14 MeSH descriptor: [Health Planning] this term only 64
#15 MeSH descriptor: [Social Control, Formal] this term only 30
#16 MeSH descriptor: [Law Enforcement] this term only 32
#17 MeSH descriptor: [Government] 2 tree(s) exploded 813
#18 MeSH descriptor: [Government Programs] this term only 30
#19 MeSH descriptor: [Government Regulation] this term only 14
#20 MeSH descriptor: [Facility Regulation and Control] this term
only
3
#21 MeSH descriptor: [Policy Making] this term only 47
#22 MeSH descriptor: [Jurisprudence] this term only 75
#23 MeSH descriptor: [Mandatory Reporting] this term only 10
#24 MeSH descriptor: [Politics] this term only 40
#25 MeSH descriptor: [Legislation as Topic] this term only 8
#26 MeSH descriptor: [Legislation, Hospital] this term only 0
#27 MeSH descriptor: [Legislation, Medical] this term only 5
#28 MeSH descriptor: [Legislation, Nursing] this term only 0
#29 MeSH descriptor: [Legislation, Pharmacy] this term only 5
#30 MeSH descriptor: [Legislation, Drug] this term only 15
#31 [mh ˆ”legislation, dental“] 0
#32 (public* or stewardship* or governance or governing or coordi-
nat* or co next ordinat* or legislat* or regulat* or government*
or law or laws or act or acts or policy or policies or politics or
reform* or control* or supervis* or monitor*)
911896
#33 #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16
or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or
#25 or #26 or #27 or #28 or #29 or #30 or #31 or #32
912008
#34 MeSHdescriptor: [Physician’s Practice Patterns] this term only 1104
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#35 MeSH descriptor: [Nurse’s Practice Patterns] this term only 62
#36 MeSH descriptor: [Dentist’s Practice Patterns] this term only 20
#37 MeSH descriptor: [Health Knowledge, Attitudes, Practice]
this term only
3833
#38 MeSH descriptor: [Malpractice] this term only 13
#39 MeSH descriptor: [Professional Impairment] this term only 0
#40 MeSH descriptor: [Physician Impairment] this term only 4
#41 MeSH descriptor: [Medical Errors] this term only 119
#42 MeSH descriptor: [Diagnostic Errors] this term only 258
#43 MeSH descriptor: [Professional Competence] this term only 211
#44 [mh ˆ”medication errors“] 228
#45 [mh ˆ”clinical competence“] 1999
#46 (competence or practice next pattern* or malpractice or mal
next practice or error*)
27575
#47 #34 or #35 or #36 or #37 or #38 or #39 or #40 or #41 or #
42 or #43 or #44 or #45 or #46
31029
#48 MeSH descriptor: [Education] this term only 498
#49 MeSH descriptor: [Competency-Based Education] this term
only
67
#50 MeSHdescriptor: [Education, PublicHealth Professional] this
term only
3
#51 MeSH descriptor: [Education, Medical] this term only 300
#52 MeSHdescriptor: [Education,Medical, Continuing] this term
only
638
#53 MeSH descriptor: [Education, Nursing] this term only 117
#54 MeSHdescriptor: [Education,Nursing,Continuing] this term
only
249
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#55 MeSH descriptor: [Education, Dental] this term only 110
#56 MeSH descriptor: [Education, Dental, Continuing] this term
only
17
#57 MeSH descriptor: [Education, Pharmacy] this term only 36
#58 [mh ˆ”education, pharmacy, continuing“] 27
#59 (educat* or train or training or trained or colloquium* or con-
ference* or course* or lecture* or meeting* or seminar* or sup-
port* or symposi* or workshop*)
383851
#60 #48 or #49 or #50 or #51 or #52 or #53 or #54 or #55 or #
56 or #57 or #58 or #59
383851
#61 MeSH descriptor: [Delivery of Health Care] this term only 751
#62 MeSH descriptor: [Quality of Health Care] this term only 933
#63 MeSH descriptor: [Quality Assurance, Health Care] this term
only
741
#64 MeSH descriptor: [Quality Improvement] this term only 216
#65 MeSH descriptor: [Total QualityManagement] this term only 172
#66 MeSH descriptor: [Outcome and Process Assessment (Health
Care)] this term only
2034
#67 MeSH descriptor: [Outcome Assessment (Health Care)] this
term only
5357
#68 MeSH descriptor: [Process Assessment (Health Care)] this
term only
129
#69 MeSH descriptor: [Guideline Adherence] this term only 748
#70 MeSH descriptor: [Benchmarking] this term only 100
#71 MeSH descriptor: [Standard of Care] this term only 91
#72 [mh ˆ”reference standards“] 357
#73 (best next practice or quality or standard* or benchmark* or
adherence or requirement*)
180929
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#74 #61 or #62 or #63 or #64 or #65 or #66 or #67 or #68 or #
69 or #70 or #71 or #72 or #73
184786
#75 (Africa or Asia or Caribbean or ”West Indies“ or ”South Amer-
ica“ or ”Latin America“ or ”Central America“)
9614
#76 (Afghanistan or Albania or Algeria or Angola or Antigua or
Barbuda or Argentina or Armenia or Armenian or Aruba or
Azerbaijan or Bahrain or Bangladesh or Barbados or Benin or
Byelarus or Byelorussian or Belarus or Belorussian or Belorus-
sia or Belize or Bhutan or Bolivia or Bosnia or Herzegovina
or Hercegovina or Botswana or Brasil or Brazil or Bulgaria or
”Burkina Faso“ or ”Burkina Fasso“ or ”Upper Volta“ or Bu-
rundi or Urundi or Cambodia or ”Khmer Republic“ or Kam-
puchea or Cameroon or Cameroons or Cameron or Camerons
or ”Cape Verde“ or ”Central African Republic“ or Chad or
Chile or China or Colombia or Comoros or ”Comoro Islands“
or Comores or Mayotte or Congo or Zaire or ”Costa Rica“ or
”Cote d’Ivoire“ or ”Ivory Coast“ or Croatia or Cuba or Cyprus
or Czechoslovakia or ”Czech Republic“ or Slovakia or ”Slovak
Republic“)
42820
#77 (Djibouti or ”French Somaliland“ or Dominica or ”Domini-
can Republic“ or ”East Timor“ or ”East Timur“ or ”Timor
Leste“ or Ecuador or Egypt or ”United Arab Republic“ or ”El
Salvador“ or Eritrea or Estonia or Ethiopia or Fiji or Gabon
or ”Gabonese Republic“ or Gambia or Gaza or Georgia or
Georgian or Ghana or ”Gold Coast“ or Greece or Grenada or
Guatemala or Guinea or Guam or Guiana or Guyana or Haiti
or Honduras or Hungary or India or Maldives or Indonesia
or Iran or Iraq or ”Isle of Man“ or Jamaica or Jordan or Kaza-
khstan or Kazakh or Kenya or Kiribati or Korea or Kosovo
or Kyrgyzstan or Kirghizia or ”Kyrgyz Republic“ or Kirghiz
or Kirgizstan or ”Lao PDR“ or Laos or Latvia or Lebanon or
Lesotho or Basutoland or Liberia or Libya or Lithuania)
40756
#78 (Macedonia or Madagascar or ”Malagasy Republic“ or
Malaysia or Malaya or Malay or Sabah or Sarawak or Malawi
or Nyasaland orMali orMalta or ”Marshall Islands“ orMauri-
tania or Mauritius or ”Agalega Islands“ or Mexico or Microne-
sia or ”Middle East“ or Moldova orMoldovia or Moldovian or
Mongolia or Montenegro or Morocco or Ifni or Mozambique
or Myanmar or Myanma or Burma or Namibia or Nepal or
”Netherlands Antilles“ or ”New Caledonia“ or Nicaragua or
Niger or Nigeria or ”Northern Mariana Islands“ or Oman or
Muscat or Pakistan or Palau or Palestine or Panama or Paraguay
or Peru or Philippines or Philipines or Phillipines or Phillip-
pines or Poland or Portugal or ”Puerto Rico“)
17933
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#79 (Romania or Rumania or Roumania or Russia or Russian or
Rwanda or Ruanda or ”Saint Kitts“ or ”St Kitts“ or Nevis or
”Saint Lucia“ or ”St Lucia“ or ”Saint Vincent“ or ”St Vincent“
or Grenadines or Samoa or ”Samoan Islands“ or ”Navigator Is-
land“ or ”Navigator Islands“ or ”Sao Tome“ or ”Saudi Arabia“
or Senegal or Serbia or Montenegro or Seychelles or ”Sierra
Leone“ or Slovenia or ”Sri Lanka“ or Ceylon or ”Solomon Is-
lands“ or Somalia or Sudan or Suriname or Surinam or Swazi-
land or Syria or Tajikistan or Tadzhikistan or Tadjikistan or
Tadzhik or Tanzania or Thailand or Togo or ”Togolese Repub-
lic“ or Tonga or Trinidad or Tobago or Tunisia or Turkey or
Turkmenistan or Turkmen or Uganda or Ukraine or Uruguay
or USSR or ”Soviet Union“ or ”Union of Soviet Socialist Re-
publics“ or Uzbekistan or Uzbek or Vanuatu or ”New He-
brides“ or Venezuela or Vietnam or ”Viet Nam“ or ”West
Bank“ or Yemen or Yugoslavia or Zambia or Zimbabwe or
Rhodesia)
23854
#80 (developing or less* next developed or ”under developed“ or
underdeveloped or ”middle income“ or low* next income or
underserved or ”under served“ or deprived or poor*) next
(countr* or nation* or population* or world)
4639
#81 (developing or less* next developed or ”under developed“ or
underdeveloped or ”middle income“ or low* next income) next
(economy or economies)
31
#82 low* next (gdp or gnp or ”gross domestic“ or ”gross national“) 34
#83 (low near/3 middle near/3 countr*) 697
#84 (lmic or lmics or ”third world“ or ”lami country“ or ”lami
countries“)
165
#85 (”transitional country“ or ”transitional countries“) 11
#86 #75 or #76 or #77 or #78 or #79 or #80 or #81 or #82 or #
83 or #84 or #85
121587
#87 #1 and #86 3
#88 #7 and #33 and #86 1386
#89 #7 and #47 and #86 497
#90 #7 and #60 and #86 1000
#91 #7 and #74 and #86 922
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#92 #87 or #88 or #89 or #90 or #91 in Other Reviews (DARE) 15
#93 #87 or #88 or #89 or #90 or #91 in Technology Assessments
(HTA)
2
MEDLINE: Epub Ahead of Print, In-Process & Other Non-Indexed Citations, MEDLINE Daily and MEDLINE 1946 to
Present, OvidSP
# Searches Results
1 Public-Private Sector Partnerships/ 1464
2 Private Sector/ 8019
3 Private Practice/ 7811
4 Hospitals, Private/ 2492
5 Privatization/ 2002
6 privat*.ti,ab. 71034
7 or/2-6 80562
8 Public Sector/ 5420
9 Public Policy/ 29034
10 Health Policy/ 55474
11 State Medicine/ 52723
12 State Dentistry/ 2224
13 Health Care Reform/ 29873
14 Health Planning/ 20949
15 Social Control, Formal/ 11298
16 Law Enforcement/ 2937
17 exp Government/ 132337
18 Government Programs/ 4139
19 Government Regulation/ 19057
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20 ”Facility Regulation and Control“/ 3144
21 Policy Making/ 13572
22 Jurisprudence/ 29305
23 Mandatory Reporting/ 2784
24 Politics/ 43289
25 Legislation as Topic/ 15676
26 Legislation, Hospital/ 2379
27 Legislation, Medical/ 16269
28 Legislation, Nursing/ 3047
29 Legislation, Pharmacy/ 1186
30 Legislation, Drug/ 9217
31 Legislation, Dental/ 1902
32 (public* or stewardship* or governance or governing or coor-
dinat* or co ordinat* or legislat* or regulat* or government*
or law or laws or act or acts or policy or policies or politics or
reform* or control* or supervis* or monitor*).ti,ab
5512906
33 or/8-32 5761440
34 Physician’s Practice Patterns/ 47211
35 Nurse’s Practice Patterns/ 1503
36 Dentist’s Practice Patterns/ 1837
37 Health Knowledge, Attitudes, Practice/ 84689
38 Malpractice/ 26511
39 Professional Impairment/ 1181
40 Physician Impairment/ 2163
41 Medical Errors/ 14062
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42 Diagnostic Errors/ 33683
43 Medication Errors/ 11292
44 Professional Competence/ 21816
45 Clinical Competence/ 73827
46 (competence or practice pattern* ormalpractice ormal practice
or error*).ti,ab
283157
47 or/34-46 547625
48 Education/ 19169
49 Competency-Based Education/ 3164
50 Education, Public Health Professional/ 686
51 Education, Medical/ 50988
52 Education, Medical, Continuing/ 22759
53 Education, Nursing/ 29751
54 Education, Nursing, Continuing/ 21849
55 Education, Dental/ 13502
56 Education, Dental, Continuing/ 3274
57 Education, Pharmacy/ 4548
58 Education, Pharmacy, Continuing/ 800
59 (educat* or train or training or trained or colloquium? or con-
ference? or course? or lecture? or meeting? or seminar? or sup-
port* or symposi* or workshop?).ti,ab
2455704
60 or/48-59 2532583
61 ”Delivery of Health Care“/ 72524
62 ”Quality of Health Care“/ 62196
63 Quality Assurance, Health Care/ 52042
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64 Quality Improvement/ 10943
65 Total Quality Management/ 12099
66 ”Outcome and Process Assessment (health care)“/ 23242
67 ”Outcome Assessment (health care)“/ 55982
68 ”Process Assessment (health care)“/ 3515
69 Guideline Adherence/ 24837
70 Benchmarking/ 11195
71 ”Standard of Care“/ 1366
72 Reference Standards/ 38051
73 (best practice or quality or standard* or benchmark* or adher-
ence or requirement*).ti,ab
1843970
74 or/61-73 2052050
75 Developing Countries.sh,kf. 76998
76 (Africa or Asia or Caribbean or West Indies or South America
or Latin America or Central America).hw,kf,ti,ab,cp
213538
77 (Afghanistan or Albania or Algeria or Angola or Antigua or
Barbuda or Argentina or Armenia or Armenian or Aruba or
Azerbaijan or Bahrain or Bangladesh or Barbados or Benin or
Byelarus or Byelorussian or Belarus or Belorussian or Belorus-
sia or Belize or Bhutan or Bolivia or Bosnia or Herzegovina
or Hercegovina or Botswana or Brasil or Brazil or Bulgaria or
Burkina Faso or Burkina Fasso or Upper Volta or Burundi or
Urundi or Cambodia or Khmer Republic or Kampuchea or
Cameroon or Cameroons or Cameron or Camerons or Cape
Verde or Central African Republic or Chad or Chile or China
or Colombia or Comoros or Comoro Islands or Comores or
Mayotte or Congo or Zaire or Costa Rica or Cote d’Ivoire or
Ivory Coast or Croatia or Cuba or Cyprus or Czechoslovakia
or Czech Republic or Slovakia or Slovak Republic or Djibouti
or French Somaliland or Dominica or Dominican Republic
or East Timor or East Timur or Timor Leste or Ecuador or
Egypt or United Arab Republic or El Salvador or Eritrea or
Estonia or Ethiopia or Fiji or Gabon or Gabonese Republic or
Gambia or Gaza or Georgia Republic or Georgian Republic
or Ghana or Gold Coast or Greece or Grenada or Guatemala
3191736
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or Guinea or Guam or Guiana or Guyana or Haiti or Hon-
duras or Hungary or India or Maldives or Indonesia or Iran
or Iraq or Isle of Man or Jamaica or Jordan or Kazakhstan or
Kazakh or Kenya or Kiribati or Korea or Kosovo or Kyrgyzs-
tan or Kirghizia or Kyrgyz Republic or Kirghiz or Kirgizstan
or Lao PDR or Laos or Latvia or Lebanon or Lesotho or Ba-
sutoland or Liberia or Libya or Lithuania or Macedonia or
Madagascar or Malagasy Republic or Malaysia or Malaya or
Malay or Sabah or Sarawak or Malawi or Nyasaland or Mali
or Malta or Marshall Islands or Mauritania or Mauritius or
Agalega Islands or Mexico or Micronesia or Middle East or
Moldova or Moldovia or Moldovian or Mongolia or Mon-
tenegro or Morocco or Ifni or Mozambique or Myanmar or
Myanma or Burma or Namibia or Nepal or Netherlands An-
tilles or New Caledonia or Nicaragua or Niger or Nigeria or
Northern Mariana Islands or Oman or Muscat or Pakistan or
Palau or Palestine or Panama or Paraguay or Peru or Philip-
pines or Philipines or Phillipines or Phillippines or Poland or
Portugal or Puerto Rico or Romania or Rumania or Roumania
or Russia or Russian or Rwanda or Ruanda or Saint Kitts or St
Kitts or Nevis or Saint Lucia or St Lucia or Saint Vincent or St
Vincent or Grenadines or Samoa or Samoan Islands or Navi-
gator Island or Navigator Islands or Sao Tome or Saudi Ara-
bia or Senegal or Serbia or Montenegro or Seychelles or Sierra
Leone or Slovenia or Sri Lanka or Ceylon or Solomon Islands
or Somalia or Sudan or Suriname or Surinam or Swaziland or
Syria or Tajikistan or Tadzhikistan or Tadjikistan or Tadzhik or
Tanzania or Thailand or Togo or Togolese Republic or Tonga
or Trinidad or Tobago or Tunisia or Turkey or Turkmenistan
or Turkmen or Uganda or Ukraine or Uruguay or USSR or
Soviet Union or Union of Soviet Socialist Republics or Uzbek-
istan or Uzbek or Vanuatu or New Hebrides or Venezuela or
Vietnam or Viet Nam or West Bank or Yemen or Yugoslavia
or Zambia or Zimbabwe or Rhodesia).hw,kf,ti,ab,cp
78 ((developing or less* developed or under developed or under-
developed or middle income or low* income or underserved
or under served or deprived or poor*) adj (countr* or nation?
or population? or world)).ti,ab
71001
79 ((developing or less* developed or under developed or under-
developed or middle income or low* income) adj (economy
or economies)).ti,ab
358
80 (low* adj (gdp or gnp or gross domestic or gross national)).ti,
ab
187
81 (low adj3 middle adj3 countr*).ti,ab. 6548
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82 (lmic or lmics or third world or lami countr*).ti,ab. 4266
83 transitional countr*.ti,ab. 127
84 or/75-83 3349766
85 randomized controlled trial.pt. 421325
86 controlled clinical trial.pt. 91035
87 pragmatic clinical trial.pt. 342
88 multicenter study.pt. 204840
89 non-randomized controlled trials as topic/ 66
90 interrupted time series analysis/ 163
91 controlled before-after studies/ 146
92 (randomis* or randomiz* or randomly or random allocat*).ti,
ab
676468
93 groups.ab. 1601971
94 (trial or multicenter or multi center or multicentre or multi
centre).ti
184051
95 (intervention* or controlled or control group or compare or
compared or (before adj5 after) or (pre adj5 post) or pretest or
pre test or posttest or post test or quasiexperiment* or quasi
experiment* or evaluat* or effect or impact or time series or
time point? or repeated measur*).ti,ab
7859186
96 or/85-95 8596750
97 Animals/ 5899594
98 Humans/ 16088033
99 97 not (97 and 98) 4232417
100 comment.pt. 673136
101 editorial.pt. 409272
102 cochrane database of systematic reviews.jn. 12472
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103 comment on.cm. 673135
104 review.pt. 2144868
105 review.ti. 325750
106 or/99-105 7253662
107 96 not 106 6192962
108 1 and 84 and 107 116
109 7 and 33 and 84 and 107 6355
110 7 and 47 and 84 and 107 932
111 7 and 60 and 84 and 107 3376
112 7 and 74 and 84 and 107 2768
113 or/108-112 7596
Embase, OvidSP
# Searches Results
1 (privat* adj6 (public* or stewardship* or governance or gov-
erning or coordinat* or co ordinat* or legislat* or regulat* or
government* or law or laws or act or acts or policy or policies
or politics or reform* or control* or supervis* or monitor*)).ti,
ab
23079
2 (privat* adj6 (competence or practice pattern* or malpractice
or mal practice or error*)).ti,ab
116
3 (privat* adj6 (educat* or train or training or trained or col-
loquium? or conference? or course? or lecture? or meeting? or
seminar? or support* or symposi* or workshop?)).ti,ab
2817
4 (privat* adj6 (best practice or quality or standard* or bench-
mark* or adherence or requirement*)).ti,ab
1329
5 or/1-4 25716
6 Developing Country.sh. 78600
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(Continued)
7 (Africa or Asia or Caribbean or West Indies or South America
or Latin America or Central America).hw,ti,ab,cp
242519
8 (Afghanistan or Albania or Algeria or Angola or Antigua or
Barbuda or Argentina or Armenia or Armenian or Aruba or
Azerbaijan or Bahrain or Bangladesh or Barbados or Benin or
Byelarus or Byelorussian or Belarus or Belorussian or Belorus-
sia or Belize or Bhutan or Bolivia or Bosnia or Herzegovina
or Hercegovina or Botswana or Brasil or Brazil or Bulgaria or
Burkina Faso or Burkina Fasso or Upper Volta or Burundi or
Urundi or Cambodia or Khmer Republic or Kampuchea or
Cameroon or Cameroons or Cameron or Camerons or Cape
Verde or Central African Republic or Chad or Chile or China
or Colombia or Comoros or Comoro Islands or Comores or
Mayotte or Congo or Zaire or Costa Rica or Cote d’Ivoire or
Ivory Coast or Croatia or Cuba or Cyprus or Czechoslovakia
or Czech Republic or Slovakia or Slovak Republic or Djibouti
or French Somaliland or Dominica or Dominican Republic or
East Timor or East Timur or Timor Leste or Ecuador or Egypt
or United Arab Republic or El Salvador or Eritrea or Estonia or
Ethiopia or Fiji or Gabon or Gabonese Republic or Gambia or
Gaza or Georgia Republic or Georgian Republic or Ghana or
Gold Coast or Greece or Grenada or Guatemala or Guinea or
Guam or Guiana or Guyana or Haiti or Honduras or Hungary
or India or Maldives or Indonesia or Iran or Iraq or Isle of Man
or Jamaica or Jordan or Kazakhstan or Kazakh or Kenya or Kiri-
bati or Korea or Kosovo or Kyrgyzstan or Kirghizia or Kyrgyz
Republic or Kirghiz or Kirgizstan or Lao PDR or Laos or Latvia
or Lebanon or Lesotho or Basutoland or Liberia or Libya or
Lithuania or Macedonia or Madagascar or Malagasy Republic
orMalaysia orMalaya orMalay or Sabah or Sarawak orMalawi
or Nyasaland or Mali or Malta or Marshall Islands or Mauri-
tania or Mauritius or Agalega Islands or Mexico or Microne-
sia or Middle East or Moldova or Moldovia or Moldovian or
Mongolia or Montenegro or Morocco or Ifni or Mozambique
or Myanmar or Myanma or Burma or Namibia or Nepal or
Netherlands Antilles or New Caledonia or Nicaragua or Niger
or Nigeria or Northern Mariana Islands or Oman or Muscat
or Pakistan or Palau or Palestine or Panama or Paraguay or
Peru or Philippines or Philipines or Phillipines or Phillippines
or Poland or Portugal or Puerto Rico or Romania or Ruma-
nia or Roumania or Russia or Russian or Rwanda or Ruanda
or Saint Kitts or St Kitts or Nevis or Saint Lucia or St Lu-
cia or Saint Vincent or St Vincent or Grenadines or Samoa
or Samoan Islands or Navigator Island or Navigator Islands or
Sao Tome or Saudi Arabia or Senegal or Serbia or Montene-
gro or Seychelles or Sierra Leone or Slovenia or Sri Lanka or
Ceylon or Solomon Islands or Somalia or Sudan or Suriname
2972104
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or Surinam or Swaziland or Syria or Tajikistan or Tadzhikistan
or Tadjikistan or Tadzhik or Tanzania or Thailand or Togo or
Togolese Republic or Tonga or Trinidad or Tobago or Tunisia
or Turkey or Turkmenistan or Turkmen or Uganda or Ukraine
or Uruguay or USSR or Soviet Union or Union of Soviet So-
cialist Republics or Uzbekistan or Uzbek or Vanuatu or New
Hebrides or Venezuela or Vietnam or Viet Nam or West Bank
or Yemen or Yugoslavia or Zambia or Zimbabwe or Rhodesia)
.hw,ti,ab,cp
9 ((developing or less* developed or under developed or under-
developed or middle income or low* income or underserved or
under served or deprived or poor*) adj (countr* or nation? or
population? or world)).ti,ab
73774
10 ((developing or less* developed or under developed or under-
developed or middle income or low* income) adj (economy or
economies)).ti,ab
382
11 (low* adj (gdp or gnp or gross domestic or gross national)).ti,
ab
207
12 (low adj3 middle adj3 countr*).ti,ab. 5147
13 (lmic or lmics or third world or lami countr*).ti,ab. 4078
14 transitional countr*.ti,ab. 157
15 or/6-14 3164473
16 Randomized Controlled Trial/ 368416
17 Controlled Clinical Trial/ 390467
18 Quasi Experimental Study/ 2348
19 Pretest Posttest Control Group Design/ 226
20 Time Series Analysis/ 15208
21 Experimental Design/ 10990
22 Multicenter Study/ 119790
23 (randomis* or randomiz* or randomly or random allocat*).ti,
ab
784492
24 groups.ab. 1818653
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25 (trial or multicentre or multicenter or multi centre or multi
center).ti
209182
26 (intervention* or controlled or control group or compare or
compared or (before adj5 after) or (pre adj5 post) or pretest or
pre test or posttest or post test or quasiexperiment* or quasi
experiment* or evaluat* or effect or impact or time series or
time point? or repeated measur*).ti,ab
8562609
27 or/16-26 9336489
28 review.ti. 320850
29 ”cochrane database of systematic reviews“.jn. 3771
30 Nonhuman/ 4494366
31 or/28-30 4795875
32 27 not 31 7358995
33 5 and 15 and 32 4227
34 limit 33 to embase 2929
Science Citation Index; Social Sciences Citation Index, ISI Web of Knowledge
TOPIC: (”public stewardship“ or ”public partnership“) OR TOPIC: ((privat*) AND (stewardship* or governance or governing or
policy or policies or politics or coordinat* or legislat* or regulat* or supervis* or monitor*) AND (health* or medical* or pharmac* or
drug or drugs or doctor* or physician* or nurse or nurses or hospital*) AND (((developing or ”less developed“ or ”lesser developed“
or underdeveloped or ”under developed“ or ”middle income“ or ”low income“ or ”lower income“ or transitional) AND (countr* or
nation* or population* or world)) or (lmic or lmics)) AND (randomis* or randomiz* or impact or effect or evaluat* or control* or
intervention* or ”time series“ or ”time point“ or ”time points“ or ”repeated measure“ or ”repeated measures“ or quasiexperiment*
or ”quasi experiment“)) OR TOPIC: ((privat*) AND (public*) AND (partnership* or engagement* or collaborat*) AND (health*
or medical* or pharmac* or drug or drugs or doctor* or physician* or nurse or nurses or hospital*) AND (((developing or ”less
developed“ or ”lesser developed“ or underdeveloped or ”under developed“ or ”middle income“ or ”low income“ or ”lower income“ or
transitional) AND (countr* or nation* or population* or world)) or (lmic or lmics)) AND (randomis* or randomiz* or impact or effect
or evaluat* or control* or intervention* or ”time series“ or ”time point“ or ”time points“ or ”repeated measure“ or ”repeated measures“
or quasiexperiment* or ”quasi experiment“))
Global Health, OvidSP
# Searches Results
1 (public stewardship or public partnership*).mp. 43
2 (private and public and (stewardship or governance or govern-
ing or policy or policies or politics or coordinate or coordina-
tion or co ordinate or co ordination or legislate or legislation or
1127
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regulat* or supervise or supervision or monitor or monitoring
or partnership or partnerships or engagement or collaborate or
collaboration or collaborating) and (randomised or randomized
or random allocation or randomly allocated or impact or im-
pacts or effect or effects or evaluate or control group or control
groups or controlled or intervention or time series or time point
or time points or repeatedmeasur* or quasiexperiment* or quasi
experiment*)).mp
3 1 or 2 1157
WHOLIS, WHO
words or phrase: ”public stewardship$ or public partnership$“
Health Management, ProQuest
(Two strategies)
1. ALL(”public stewardship“ or ”public partnership“)
2. ALL(privat*) and ALL(public* or stewardship* or (national NEAR/3 program*) or governance) and ALL(coordinat* or (co PRE/
0 ordinat*) or educat* or train or training or regulat*) and ALL((Africa or Asia or Caribbean or ”West Indies“ or ”South America“
or ”Latin America“ or ”Central America“ or Afghanistan or Albania or Algeria or Angola or Antigua or Barbuda or Argentina or
Armenia or Armenian or Aruba or Azerbaijan or Bahrain or Bangladesh or Barbados or Benin or Byelarus or Byelorussian or Belarus
or Belorussian or Belorussia or Belize or Bhutan or Bolivia or Bosnia or Herzegovina or Hercegovina or Botswana or Brasil or Brazil
or Bulgaria or ”Burkina Faso“ or ”Burkina Fasso“ or ”Upper Volta“ or Burundi or Urundi or Cambodia or ”Khmer Republic“ or
Kampuchea or Cameroon or Cameroons or Cameron or Camerons or ”Cape Verde“ or ”Central African Republic“ or Chad or Chile
or China or Colombia or Comoros or ”Comoro Islands“ or Comores or Mayotte or Congo or Zaire or ”Costa Rica“ or ”Cote d’Ivoire“
or ”Ivory Coast“ or Croatia or Cuba or Cyprus or Czechoslovakia or ”Czech Republic“ or Slovakia or ”Slovak Republic“ or Djibouti or
”French Somaliland“ or Dominica or ”Dominican Republic“ or ”East Timor“ or ”East Timur“ or ”Timor Leste“ or Ecuador or Egypt or
”United Arab Republic“ or ”El Salvador“ or Eritrea or Estonia or Ethiopia or Fiji or Gabon or ”Gabonese Republic“ or Gambia or Gaza
or ”Georgia Republic“ or ”Georgian Republic“ or Ghana or ”Gold Coast“ or Greece or Grenada or Guatemala or Guinea or Guam or
Guiana or Guyana or Haiti or Honduras or Hungary or India or Maldives or Indonesia or Iran or Iraq or ”Isle of Man“ or Jamaica or
Jordan or Kazakhstan or Kazakh or Kenya or Kiribati or Korea or Kosovo or Kyrgyzstan or Kirghizia or ”Kyrgyz Republic“ or Kirghiz
or Kirgizstan or ”Lao PDR“ or Laos or Latvia or Lebanon or Lesotho or Basutoland or Liberia or Libya or Lithuania or Macedonia or
Madagascar or ”Malagasy Republic“ or Malaysia or Malaya or Malay or Sabah or Sarawak or Malawi or Nyasaland or Mali or Malta or
”Marshall Islands“ or Mauritania or Mauritius or ”Agalega Islands“ or Mexico or Micronesia or ”Middle East“ or Moldova or Moldovia
or Moldovian or Mongolia or Montenegro or Morocco or Ifni or Mozambique or Myanmar or Myanma or Burma or Namibia or
Nepal or ”Netherlands Antilles“ or ”New Caledonia“ or Nicaragua or Niger or Nigeria or ”Northern Mariana Islands“ or Oman or
Muscat or Pakistan or Palau or Palestine or Panama or Paraguay or Peru or Philippines or Philipines or Phillipines or Phillippines or
Poland or Portugal or Puerto Rico or Romania or Rumania or Roumania or Russia or Russian or Rwanda or Ruanda or ”Saint Kitts“ or
”St Kitts“ or Nevis or ”Saint Lucia“ or ”St Lucia“ or ”Saint Vincent“ or ”St Vincent“ or Grenadines or Samoa or ”Samoan Islands“ or
”Navigator Island“ or ”Navigator Islands“ or ”Sao Tome“ or ”Saudi Arabia“ or Senegal or Serbia or Montenegro or Seychelles or ”Sierra
Leone“ or Slovenia or ”Sri Lanka“ or Ceylon or ”Solomon Islands“ or Somalia or Sudan or ”South Africa“ or Suriname or Surinam or
Swaziland or Syria or Tajikistan or Tadzhikistan or Tadjikistan or Tadzhik or Tanzania or Thailand or Togo or ”Togolese Republic“ or
Tonga or Trinidad or Tobago or Tunisia or Turkey or Turkmenistan or Turkmen or Uganda or Ukraine or Uruguay or USSR or ”Soviet
Union“ or ”Union of Soviet Socialist Republics“ or Uzbekistan or Uzbek or Vanuatu or ”New Hebrides“ or Venezuela or Vietnam
or” Viet Nam“ or ”West Bank“ or Yemen or Yugoslavia or Zambia or Zimbabwe or Rhodesia or lmic or lmics or ”third world“ or
”lami country“ or ”lami countries“ or ”transitional country“ or ”transitional countries“) or (developing or ”less developed“ or ”lesser
developed“ or ”under developed“ or underdeveloped or ”middle income“ or ”low income“ or ”lower income“ or underserved or ”under
served“ or deprived or poor*) PRE/0 (countr* or nation* or population* or world or economy or economies)) and ALL(randomised or
randomized or ”randomly allocated“ or ”random allocation“ or trial or intervention or interventions or controlled or ”control group“
or ”before and after“ or ”pre and post“ or pretest or ”pre test“ or posttest or ”post test“ or quasiexperiment or quasiexperimental or
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evaluate or effect or impact or ”time series“ or ”time point“ or ”time points“ or ”repeated measure“ or ”repeated measures“ or ”repeated
measurement“ or ”repeated measurements“)
OpenGrey
((stewardship* OR partnership*) OR (privat* AND public*)) AND (05T Health services, health administration, community care
services)
The Grey Literature Report
1. Keywords:public stewardship and tick off for Grey Literature under: Collection codes
2. Title:public stewardship and tick off for Grey Literature under: Collection codes
3. Keywords:private stewardship and tick off for Grey Literature under: Collection codes
4. Title:private stewardship and tick off for Grey Literature under: Collection codes
5. Keywords:public partnership and tick off for Grey Literature under: Collection codes
6. Title:public partnership and tick off for Grey Literature under: Collection codes
7. Keywords:private partnership and tick off for Grey Literature under: Collection codes
8. Title:private partnership and tick off for Grey Literature under: Collection codes
World Bank e-Library
[Title: stewardship* OR partnership* OR (privat* AND public*)] AND [Keyword: stewardship* OR partnership* OR (privat* AND
public*)] AND [Abstract: stewardship* OR partnership* OR (privat* AND public*)]
International Clinical Trials Registry Platform
1. private AND public (in title) and set Recruitment status to ALL
2. private AND public (in intervention) and set Recruitment status to ALL
3. stewardship OR stewardships OR partnership OR partnerships (in title) and set Recruitment status to ALL
4. stewardship OR stewardships OR partnership OR partnerships (in intervention) and set Recruitment status to ALL
ClinicalTrials.gov
In Search Terms
(private OR public) AND (stewardship OR stewardships OR partnership OR partnerships)
US National Institutes of Health
In Search Terms
(private OR public) AND (stewardship OR stewardships OR partnership OR partnerships)
United Nations Children’s Fund
In Search Terms
(private OR public) AND (stewardship OR stewardships OR partnership OR partnerships)
Alliance for Health Policy and Systems Research
In Search Terms
(private OR public) AND (stewardship OR stewardships OR partnership OR partnerships)
United States Agency for International Development
In Search Terms
(private OR public) AND (stewardship OR stewardships OR partnership OR partnerships)
Gavi, The Vaccine Alliance
In Search Terms
(private OR public) AND (stewardship OR stewardships OR partnership OR partnerships)
Private Healthcare in Developing Countries
In Search Terms
(private OR public) AND (stewardship OR stewardships OR partnership OR partnerships)
Population Services International
In Search Terms
(private OR public) AND (stewardship OR stewardships OR partnership OR partnerships)
Shops
In Search Terms
(private OR public) AND (stewardship OR stewardships OR partnership OR partnerships)
Department for International Development
In Search Terms
(private OR public) AND (stewardship OR stewardships OR partnership OR partnerships)
Center For Health Market Innovations
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In Search Terms
(private OR public) AND (stewardship OR stewardships OR partnership OR partnerships)
World Bank
In Search Terms
(private OR public) AND (stewardship OR stewardships OR partnership OR partnerships)
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Medical Subject Headings (MeSH)
∗Developing Countries; Government Regulation; Health Personnel [∗education]; Health Services [legislation & jurisprudence;
∗standards]; Indonesia; Kenya; Laos; Pharmacies [legislation & jurisprudence; ∗standards]; Private Sector [legislation & jurisprudence;
∗standards]; Quality Improvement; Randomized Controlled Trials as Topic; Thailand; Vietnam
MeSH check words
Humans
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